Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3027315	b-po2	kPa (kpa)	9220	35844	1.78%
3027315	b-po2	— (—)	797	1249	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

COPD (mode)

872

1550

4.57

323.31

6.7

2.6

8.03

8.79

kpa

28.26

853

1510

Acute tubulo-interstitial nephritis

1563

4555

2.98

320.16

5.6

3.0

8.53

8.68

kpa

2.38

1530

4444

Care involving dialysis

429

552

8.75

318.35

13.5

3.6

9.05

8.56

kpa

5.42

423

540

Bacterial infection, other or unspecified

1467

4149

3.08

317.32

5.8

3.3

8.42

8.61

kpa

3.54

1436

4048

Sleep apnoea

2228

5646

2.55

315.34

4.3

3.8

8.71

8.63

kpa

1.23

2185

5510

Persons encountering health services for specific procedures and health care

2406

5898

2.46

311.53

5.8

3.0

8.76

8.73

kpa

0.27

2371

5733

Any gastric operation

1522

2385

3.26

310.04

4.8

2.5

8.87

8.78

kpa

0.79

1497

2311

GASTRO-related operations

1522

2385

3.26

310.04

4.8

2.5

8.87

8.78

kpa

0.79

1497

2311

Other disorders of fluid, electrolyte and acid-base balance

1179

2803

4.18

307.65

6.0

3.7

8.47

8.52

kpa

0.36

1145

2738

Other diseases of pleura

1554

3845

3.68

307.65

7.6

3.4

8.17

8.53

kpa

12.44

1525

3744

Renal failure

1895

3979

4.30

307.65

7.6

3.3

8.47

8.48

kpa

0.04

1852

3880

Asthma, unspecified (mode), excluding more controls

1124

2127

3.88

307.65

4.6

2.4

8.59

9.06

kpa

12.71

1103

2071

Other bacterial diseases, including avohilmo

2590

5631

2.95

307.65

5.3

3.2

8.51

8.80

kpa

10.92

2528

5498

All pneumoniae

2698

5689

3.17

307.65

5.8

2.9

8.45

8.91

kpa

27.68

2640

5561

Renal tubulo-interstitial diseases

2647

5572

3.61

307.65

6.3

3.0

8.59

8.73

kpa

3.07

2591

5441

Condition for Implicit Sepsis (Organ dysfunction codes)

2350

4989

3.37

307.65

6.2

2.6

8.42

8.80

kpa

18.12

2297

4870

Bacterial Sepsis

1544

3461

3.85

307.65

7.3

2.8

8.24

8.63

kpa

14.03

1500

3375

Other heart diseases

1078

1506

4.79

307.65

5.4

2.5

8.78

9.13

kpa

5.44

1064

1470

Implicit bacterial Sepsis

1373

3163

3.89

307.65

7.6

2.9

8.20

8.59

kpa

12.46

1334

3084

All kidney diseases

2675

5693

3.24

307.65

6.0

2.9

8.64

8.77

kpa

2.70

2617

5555

Malaise and fatigue

1511

3113

3.96

307.65

4.5

3.7

8.71

8.65

kpa

0.54

1470

3034

Respiratory insufficiency

470

438

12.02

307.65

12.4

2.5

7.83

8.76

kpa

16.19

462

426

Septicaemia

1474

3533

3.99

307.65

7.0

3.4

8.47

8.58

kpa

1.40

1433

3450

Other bacterial diseases

2595

5629

3.15

307.65

5.5

3.3

8.50

8.74

kpa

7.73

2536

5497

First line medication for Crohn's disease

2509

5333

2.58

307.65

5.0

3.1

8.72

8.74

kpa

0.28

2460

5186

Influenza and pneumonia

2705

5581

3.07

307.65

5.6

2.8

8.51

8.92

kpa

21.95

2649

5453

Explicit Sepsis, including avohilmo

1538

3517

4.15

307.65

7.0

2.8

8.48

8.66

kpa

2.88

1496

3432

Oral corticosteroids

2513

5983

2.52

307.65

5.0

3.4

8.53

8.74

kpa

6.58

2463

5824

Other septicaemia, including avohilmo

1362

3292

4.08

307.65

7.1

3.4

8.47

8.57

kpa

1.01

1324

3214

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2361

4003

3.55

307.65

5.7

2.9

8.46

8.87

kpa

18.41

2310

3915

Other medical care

1583

3813

3.63

307.65

5.5

3.2

8.36

8.53

kpa

2.96

1568

3700

Other septicaemia

1340

3234

4.10

307.65

7.1

3.4

8.48

8.56

kpa

0.78

1303

3157

Persons encountering health services in other circumstances

1754

3462

5.33

307.65

4.4

3.2

8.74

8.66

kpa

0.87

1696

3391

Nephropathy related operations

589

1026

6.34

307.65

12.4

4.1

9.04

8.54

kpa

5.77

581

1012

Heart failure, not strict

2182

4062

3.75

307.65

6.4

2.9

8.35

8.77

kpa

18.78

2135

3970

Presence of other functional implants

1789

3866

3.29

307.65

4.3

3.9

8.49

8.48

kpa

0.05

1751

3755

Fever of other and unknown origin

1819

3635

4.51

307.65

5.3

3.6

8.54

8.74

kpa

4.11

1781

3541

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2622

5777

3.11

307.65

5.8

2.9

8.44

8.90

kpa

26.79

2566

5647

Heart failure,strict

1677

3024

4.05

307.65

6.4

3.0

8.17

8.70

kpa

23.70

1643

2955

Acute renal failure

853

1991

4.56

307.65

7.8

3.3

8.23

8.52

kpa

4.51

833

1941

Dyspnoea

2489

6094

3.04

307.65

4.9

3.6

8.50

8.70

kpa

5.72

2432

5942

Implicit Sepsis, including avohilmo

2377

4958

3.54

307.65

6.3

2.7

8.41

8.78

kpa

17.09

2325

4839

Heart failure, strict

1819

3774

3.49

307.65

6.3

3.4

8.15

8.63

kpa

21.36

1782

3682

2361

4003

3.55

307.65

5.7

2.9

8.46

8.87

kpa

18.41

2310

3915

Implicit Sepsis

2296

4785

3.67

307.65

6.6

2.7

8.37

8.74

kpa

16.56

2247

4667

Pneumonia, organism unspecified

2606

5323

3.47

307.65

5.8

2.8

8.43

8.89

kpa

26.39

2554

5200

Invasive ventilation

437

545

9.17

307.65

8.7

4.0

8.70

8.59

kpa

0.45

413

537

Bacterial infection, other or unspecified, including avohilmo

1570

4364

3.04

307.65

5.8

3.3

8.40

8.64

kpa

5.77

1535

4262

ILD medications: prednisolone, methylprednisolone, prednisone

2488

5674

2.49

307.65

5.4

3.1

8.64

8.74

kpa

1.77

2441

5518

Hypertensive diseases (excluding secondary)

1059

1459

4.33

307.65

5.1

2.5

8.86

9.09

kpa

2.77

1038

1424

Heart failure and antihypertensive medication

850

834

7.01

307.65

7.0

2.8

8.22

8.78

kpa

10.04

833

811

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2539

6196

2.83

307.65

5.4

3.4

8.56

8.72

kpa

4.02

2484

6046

All-cause Heart Failure

1790

3713

3.50

307.65

6.2

3.4

8.16

8.62

kpa

19.81

1753

3624

Dialysis, with operation codes

579

937

6.78

307.65

12.3

3.6

9.01

8.61

kpa

3.86

571

923

Chronic kidney disease

1387

2976

4.80

307.65

8.3

3.3

8.59

8.45

kpa

1.88

1360

2897

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

2362

5022

3.27

307.65

6.0

2.6

8.49

8.83

kpa

13.64

2310

4901

Explicit Sepsis

1513

3465

4.17

307.65

7.0

2.8

8.48

8.65

kpa

2.52

1472

3382

Implicit bacterial Sepsis, including avohilmo

1471

3394

3.76

307.65

7.4

2.8

8.21

8.62

kpa

14.40

1431

3309

Pneumonias (Asthma/COPD co-morbidities)

2695

5673

3.19

307.65

5.7

2.9

8.45

8.91

kpa

26.68

2637

5546

Abnormalities of breathing

2240

4119

3.19

307.65

4.5

3.5

8.67

8.77

kpa

1.60

2188

4016

All chronic kidney diseases

1912

3791

4.21

307.65

7.1

3.0

8.64

8.63

kpa

0.09

1870

3698

General symptoms and signs

2369

4118

2.94

307.65

4.3

3.6

8.75

8.80

kpa

0.52

2319

4017

Heart failure and coronary heart disease

1297

2808

3.37

305.51

6.4

3.7

8.13

8.47

kpa

8.25

1268

2736

Other heart diseases, wide

1911

4376

2.70

300.40

4.9

3.2

8.69

8.93

kpa

5.71

1877

4274

Asthma, unspecified (mode)

1176

2493

3.49

299.48

4.6

2.5

8.58

8.96

kpa

9.08

1153

2430

Sleep apnoea, including avohilmo

2274

5691

2.47

299.18

4.2

3.8

8.71

8.65

kpa

0.64

2226

5554

Implicit viral Sepsis, including avohilmo

925

2500

3.85

294.48

7.2

2.8

8.51

8.71

kpa

2.44

903

2443

Exposure to unspecified factor

2371

6964

2.36

293.27

4.4

3.8

8.66

8.72

kpa

0.87

2326

6790

Other respiratory disorders and diseases

791

1944

4.33

290.90

10.5

3.4

8.04

8.52

kpa

11.80

775

1892

Other diseases of the respiratory system

791

1944

4.33

290.90

10.5

3.4

8.04

8.52

kpa

11.80

775

1892

Inflammatory bowel disease treatment related agents

2522

6131

2.32

285.27

4.9

3.4

8.60

8.77

kpa

4.30

2471

5970

ILD medications

2457

5760

2.34

280.22

5.3

3.1

8.65

8.75

kpa

2.06

2412

5603

Implicit viral Sepsis

706

1665

4.47

273.09

8.0

2.7

8.54

8.69

kpa

1.19

690

1624

Viral Sepsis

706

1669

4.46

272.23

8.0

2.7

8.54

8.68

kpa

1.16

690

1628

Cardiovascular diseases (excluding rheumatic etc)

1163

1960

3.46

271.74

4.7

2.5

9.02

9.24

kpa

2.88

1143

1914

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2153

5796

2.39

269.06

5.2

3.5

8.73

8.72

kpa

0.02

2114

5636

Oxycodone

1093

2914

3.32

268.15

5.3

3.9

8.44

8.50

kpa

0.54

1070

2836

Any death

1587

4153

2.76

267.86

6.3

3.2

8.36

8.68

kpa

8.75

1551

4068

Insulin medication

1544

4831

2.73

267.55

5.9

3.6

8.52

8.62

kpa

1.41

1503

4725

COPD/asthma/ILD related infections

2002

4003

2.55

267.10

4.7

2.9

8.60

8.87

kpa

7.08

1959

3915

COPD/asthma related infections

2002

4003

2.55

267.10

4.7

2.9

8.60

8.87

kpa

7.08

1959

3915

Valvular heart disease excluding rheumatic fever

1135

2513

3.32

266.18

5.1

3.4

8.39

8.72

kpa

6.30

1114

2449

Asthma, excluding more controls

1354

2254

3.14

262.83

4.4

2.3

8.70

9.09

kpa

9.70

1333

2193

Non-rheumatic valve diseases

1127

2503

3.31

262.66

5.1

3.4

8.39

8.72

kpa

5.95

1106

2440

Heart failure and bmi 25plus

1157

2432

3.33

261.33

6.3

3.4

8.20

8.64

kpa

12.82

1131

2368

Pain in throat and chest

1760

4047

2.62

261.33

3.8

3.5

8.79

8.76

kpa

0.33

1733

3946

Atrial fibrillation and flutter

683

916

4.96

260.60

5.2

2.5

8.41

8.96

kpa

10.63

672

892

Pulmonary heart disease, diseases of pulmonary circulation

1003

3108

3.37

260.10

5.8

3.9

8.21

8.54

kpa

6.54

984

3024

Convulsions, not elsewhere classified

669

1557

4.41

256.83

4.6

3.7

8.69

8.84

kpa

1.21

657

1526

Hypertensive diseases

1565

3250

2.77

253.46

5.1

3.0

8.74

8.82

kpa

0.82

1533

3172

Hypertension

1563

3248

2.77

252.74

5.1

3.0

8.74

8.82

kpa

0.77

1531

3170

Cardiac arrhythmias

1107

2182

3.32

252.65

4.3

2.8

8.74

9.07

kpa

6.16

1091

2135

Intracranial trauma

1269

2903

3.02

252.12

4.0

3.8

8.58

8.80

kpa

3.73

1238

2840

Type 2 diabetes, wide definition

1792

4591

2.52

248.39

5.4

3.5

8.52

8.60

kpa

1.05

1742

4484

Glomerular diseases

650

1557

4.44

247.41

9.4

4.1

8.82

8.59

kpa

2.50

638

1528

Contact with and exposure to communicable diseases

791

2160

3.77

246.32

3.4

3.7

9.09

9.06

kpa

0.18

775

2117

Any reimbursement code in KELA

951

1269

3.82

242.03

4.4

2.0

8.96

9.14

kpa

1.63

931

1236

Acute bronchitis

1155

3955

2.96

241.44

5.7

3.8

8.49

8.66

kpa

2.63

1129

3843

Syncope and collapse

1072

2926

3.14

240.81

3.8

3.7

8.50

8.63

kpa

1.39

1044

2851

Hypertension, essential

1509

3168

2.75

240.69

4.8

2.9

8.70

8.81

kpa

1.23

1481

3092

Tramadol

1658

3935

2.58

239.85

4.6

3.6

8.58

8.69

kpa

1.49

1611

3831

Atrial fibrillation and flutter with reimbursement

567

669

5.52

238.92

5.1

2.6

8.28

8.85

kpa

8.70

558

650

Bronchitis

2368

6599

2.19

238.63

4.8

3.6

8.62

8.70

kpa

1.25

2313

6439

Erysipelas, including avohilmo

1622

4870

2.52

235.68

5.0

3.3

8.36

8.70

kpa

11.24

1586

4753

Asthma

1426

2631

2.85

235.64

4.5

2.5

8.67

8.99

kpa

7.52

1401

2563

Codeine

1876

4222

2.44

235.31

3.8

3.5

8.72

8.77

kpa

0.47

1840

4113

Asthma (only as main-diagnosis), excluding more controls

1227

2254

3.06

235.29

4.3

2.3

8.71

9.09

kpa

8.66

1210

2193

Other acute lower respiratory infections

1396

5167

2.64

235.09

5.6

3.8

8.53

8.66

kpa

2.03

1369

5027

Concussion

1110

2881

3.05

234.23

3.8

8.62

8.80

kpa

2.50

1085

2819

Aplastic and other anaemias

1296

4445

2.76

233.42

6.2

3.8

8.45

8.49

kpa

0.33

1255

4341

Diseases of arteries, arterioles and capillaries (FINNGEN)

538

706

5.44

232.17

6.1

2.6

8.45

8.90

kpa

5.30

530

685

Substance abuse, excluding more controls

1334

4216

2.71

229.98

4.5

3.7

8.57

8.68

kpa

1.38

1299

4139

Hypo-osmolality and hyponatraemia

628

1536

4.29

229.09

5.2

3.8

8.50

kpa

0.01

609

1495

Insulin, combination of fast acting with intermediate-acting or long-acting

1546

5773

2.49

228.22

5.9

3.8

8.52

8.60

kpa

0.89

1504

5634

Early onset COPD, excluding more controls

535

1163

4.79

228.22

6.9

2.7

8.15

8.87

kpa

16.71

524

1132

Ischemic heart diseases

1738

4284

2.47

227.70

5.1

3.5

8.52

8.71

kpa

3.90

1705

4173

Extracorporeal dialysis

334

482

7.87

224.95

14.0

4.8

8.93

8.47

kpa

3.83

328

474

Insulin, fast-acting

1012

3433

3.05

224.10

6.3

3.7

8.60

8.69

kpa

0.80

990

3356

Benzodiazepine use

2201

6960

2.17

223.90

4.5

3.8

8.67

8.69

kpa

0.19

2141

6801

Insulin, intermediate and long-acting

1402

5409

2.57

223.50

5.8

3.8

8.50

8.59

kpa

1.30

1366

5285

Metabolic disorders

2010

5408

2.27

220.64

4.8

3.5

8.63

8.70

kpa

0.79

1960

5281

ILD medications: immunosuppressive drugs

1394

5048

2.56

218.26

6.2

3.1

8.80

8.78

kpa

0.20

1373

4920

Symptoms and signs involving the circulatory and respiratory systems

1912

4124

2.36

218.10

4.1

3.5

8.78

8.77

kpa

0.05

1881

4021

Pulmonary embolism

883

2826

3.26

217.02

5.3

3.9

8.36

8.55

kpa

2.42

866

2750

Diabetes mellitus

2087

5516

2.22

215.93

4.7

3.4

8.73

8.74

kpa

0.08

2032

5390

Persons encountering health services in other circumstances, wide

2362

5770

2.14

215.64

5.2

3.3

8.72

8.64

kpa

1.11

2292

5644

Persons with potential health hazards related to communicable diseases

893

2873

3.17

212.39

3.6

3.8

9.06

8.96

kpa

0.93

875

2818

Pulmonary heart disease

883

2871

3.21

211.31

5.3

4.0

8.36

8.52

kpa

1.85

866

2794

Diabetes, varying definitions

2069

5529

2.21

210.69

4.7

3.4

8.73

8.74

kpa

0.07

2014

5402

Non-ischemic cardiomyopathy

826

1974

3.44

210.01

5.9

3.2

8.25

8.60

kpa

5.96

809

1925

Opioids

1894

4298

2.31

208.37

4.1

3.5

8.78

kpa

0.01

1858

4184

Insulin, fast-acting or short human

1016

3595

2.92

208.36

6.3

3.7

8.61

8.67

kpa

0.47

994

3511

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1938

5208

2.25

207.14

5.0

3.4

8.68

8.69

kpa

0.08

1882

5087

Hard cardiovascular diseases

1697

4305

2.38

205.11

4.8

3.6

8.53

8.71

kpa

3.63

1661

4202

COPD

1189

3649

2.73

205.04

6.5

3.7

8.05

8.54

kpa

19.93

1163

3559

Disorders of other endocrine glands

1095

3988

2.78

205.04

5.6

3.6

8.80

8.72

kpa

0.68

1081

3889

Other and unspecified anaemias

1176

4220

2.70

204.94

5.9

3.9

8.43

8.47

kpa

0.36

1136

4123

Asthma (only as main-diagnosis)

1274

2631

2.75

204.23

4.3

2.5

8.71

8.99

kpa

5.53

1255

2563

Other anaemias

1180

4243

2.69

203.44

5.9

3.8

8.42

8.47

kpa

0.41

1140

4146

Percutaneous Coronary Intervention

1618

4174

2.41

202.54

5.1

3.5

8.50

8.69

kpa

3.61

1590

4066

Other pulmonary diagnosis

1389

2655

2.66

202.24

4.6

2.5

8.60

9.00

kpa

10.75

1364

2587

Covid-19 confirmed case

1045

3817

2.83

201.58

5.3

3.9

8.59

8.58

kpa

0.07

1031

3716

Cardiovascular diseases

1020

1750

3.15

201.44

4.5

2.5

9.10

9.28

kpa

2.00

1003

1708

Mental and behavioural disorders due to psychoactive substance use

1412

5416

2.44

201.05

4.5

4.0

8.59

8.68

kpa

1.18

1371

5304

Venous thromboembolism

1330

5257

2.50

200.39

5.0

3.9

8.44

8.52

kpa

0.94

1303

5117

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

354

361

7.26

198.39

7.2

3.1

8.37

8.61

kpa

1.22

349

353

Adjustment and management of implanted device

594

1576

3.97

196.00

4.6

3.4

8.41

8.44

kpa

0.16

583

1521

Excluding asthma or asthma-COPD overlap

1374

2655

2.63

195.99

4.6

2.5

8.61

9.00

kpa

10.35

1350

2587

Coronary revascularization (ANGIO or CABG)

1603

4175

2.38

195.91

5.1

3.5

8.52

8.69

kpa

3.13

1575

4067

Cerebrovascular diseases (FINNGEN)

582

975

4.29

194.79

4.6

2.7

8.59

8.98

kpa

4.98

566

951

2277

5631

2.08

193.66

4.6

3.5

8.57

8.70

kpa

2.57

2224

5490

Endocrine, nutritional and metabolic diseases

1439

2891

2.55

193.64

4.5

2.9

8.86

8.85

kpa

0.07

1410

2821

Erysipelas

1275

4451

2.53

192.70

5.4

3.3

8.32

8.64

kpa

8.94

1246

4345

ILD, hospital admission 2, with pulmonary infections

363

659

5.90

192.36

7.4

3.1

8.14

8.59

kpa

4.75

354

641

ILD differential diagnosis

1361

2646

2.62

191.89

4.6

2.5

8.61

8.99

kpa

10.05

1337

2578

Glomerular disorders in diseases classified elsewhere

447

977

4.92

191.86

9.8

4.2

8.73

8.54

kpa

1.33

440

960

COPD differential diagnosis

1361

2647

2.62

191.79

4.6

2.5

8.61

8.99

kpa

10.09

1337

2579

Diabetes, insulin treatment (Kela reimbursement)

2073

5934

2.11

191.22

5.0

3.5

8.65

8.67

kpa

0.19

2014

5800

Other chronic obstructive pulmonary disease

1128

3523

2.70

191.19

6.7

3.7

8.06

8.53

kpa

18.15

1100

3436

Type 2 diabetes

1949

5293

2.17

190.03

4.7

3.3

8.67

8.70

kpa

0.31

1897

5170

DVT of lower extremities and pulmonary embolism

1091

4193

2.67

188.85

5.1

4.0

8.43

8.52

kpa

0.95

1069

4081

Asthma (mode)

1305

2646

2.63

188.79

4.0

2.5

8.73

8.99

kpa

4.91

1283

2578

Parasetamol

1350

2672

2.59

187.69

4.4

3.4

8.79

8.86

kpa

0.56

1328

2598

Pacemaker

1027

3573

2.77

186.72

4.9

4.3

8.32

8.41

kpa

0.85

1008

3477

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

629

1759

3.64

186.14

4.2

3.5

9.04

8.91

kpa

0.94

605

1729

Diarrhoea and gastroenteritis of presumed infectious origin

1569

6367

2.24

183.22

5.4

3.5

8.70

kpa

0.01

1536

6209

Nausea and vomiting

722

2203

3.30

182.43

5.3

3.9

8.80

8.55

kpa

3.15

704

2142

1407

5319

2.35

182.26

4.6

4.0

8.57

8.66

kpa

1.20

1367

5208

Viral pneumonia

415

888

4.93

181.64

6.6

3.0

8.43

8.78

kpa

3.88

406

866

Other antidepressants

2072

5111

2.10

181.14

4.3

3.8

8.66

8.67

kpa

0.16

2016

5006

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

723

1317

3.53

180.11

4.5

2.4

8.86

9.07

kpa

1.67

717

1285

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

693

2071

3.38

179.99

3.7

4.2

8.73

8.39

kpa

4.10

682

2018

Major coronary heart disease event

1704

4656

2.23

179.35

5.1

3.6

8.51

8.65

kpa

2.23

1668

4539

1358

5243

2.37

179.13

4.5

4.0

8.57

8.66

kpa

1.07

1318

5133

Episodal and paroxysmal disorders

2096

5180

2.08

178.85

4.0

3.7

8.82

8.68

kpa

2.41

2049

5054

Headache

1198

3718

2.53

178.67

4.0

3.5

8.83

kpa

0.01

1168

3626

L04AA Selective immunosuppressants

623

1827

3.56

176.57

8.2

3.7

8.96

8.72

kpa

2.46

617

1795

Substance abuse

1334

5368

2.36

176.54

4.5

4.0

8.57

8.68

kpa

1.45

1299

5257

COPD, hospital admissions

1149

3898

2.56

175.79

6.6

3.8

8.03

8.51

kpa

18.92

1120

3809

ILD, hospital admissions 3, with pneumonia sepsis

328

593

5.96

174.90

7.6

3.3

8.08

8.54

kpa

4.44

320

578

Mental and behavioural disorders due to alcohol

1213

4846

2.44

173.74

4.4

4.0

8.57

8.67

kpa

1.21

1178

4746

Bleeding

1779

5981

2.12

172.58

5.3

3.7

8.49

8.63

kpa

2.68

1736

5839

Other chronic obstructive pulmonary disease, including avohilmo

1298

4566

2.40

172.24

6.2

3.8

8.09

8.55

kpa

19.79

1263

4461

Complications of surgical and medical care, not elsewhere classified

2052

6894

2.02

172.16

5.1

3.7

8.70

8.65

kpa

0.47

2020

6711

406

890

4.78

172.14

5.1

3.0

9.14

8.75

kpa

3.40

395

874

Codeine or tramadol medication

2228

6168

1.99

171.70

3.9

8.68

8.69

kpa

0.10

2184

6015

COPD, early/later onset

1149

3930

2.53

171.27

6.6

3.8

8.04

8.52

kpa

18.82

1121

3842

Hernia of abdominal wall, postoperative

425

961

4.54

170.65

5.7

2.7

8.71

8.54

kpa

1.10

417

934

COPD related to multimorbidity

1043

3450

2.64

169.65

6.8

3.8

8.03

8.48

kpa

15.13

1014

3372

Emergency coronary revascularization (for ACS)

1748

4991

2.15

169.35

5.1

3.7

8.49

8.61

kpa

1.72

1717

4855

Volume depletion

382

813

5.03

169.13

6.8

4.0

8.53

8.37

kpa

0.82

372

791

Extreme obesity with alveolar hypoventilation

218

267

9.27

168.96

9.6

3.4

8.23

8.61

kpa

1.77

213

261

Poisoning by medicine

574

1641

3.63

168.86

4.4

3.8

8.99

8.87

kpa

0.70

556

1614

COPD, hospital admission 2, with asthma infections

904

2853

2.83

168.18

7.3

3.8

7.94

8.50

kpa

20.35

881

2787

Pleural effusion

497

1306

4.01

166.47

6.4

3.4

8.23

8.51

kpa

2.66

489

1271

Diabetes medication

2026

5936

2.02

166.26

4.8

3.4

8.71

kpa

0.01

1970

5802

Poisoning by drugs, medicaments and biological substances

610

1831

3.45

166.20

4.4

3.9

8.98

8.86

kpa

0.76

592

1801

Other CVD (FINNGEN)

303

362

6.68

165.56

4.9

2.7

8.57

8.78

kpa

0.90

294

353

Certain infectious and parasitic diseases

1755

4127

2.16

163.86

4.8

2.9

8.71

8.81

kpa

1.27

1721

4027

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

465

1176

4.13

163.72

4.5

3.7

9.00

8.92

kpa

0.37

452

1158

Paroxysmal tachycardia

434

828

4.47

162.40

4.7

2.7

8.73

8.96

kpa

1.55

423

811

Sleep disorders (combined)

2134

5686

1.99

162.40

4.1

3.8

8.74

8.65

kpa

1.18

2090

5541

Intestinal infectious diseases

1938

7323

2.00

162.20

5.2

3.6

8.73

8.69

kpa

0.47

1892

7149

Coronary atherosclerosis

1311

3564

2.37

160.35

5.0

3.5

8.47

8.64

kpa

2.64

1287

3470

Obesity related asthma

842

3103

2.80

159.93

5.2

3.8

8.67

8.72

kpa

0.38

831

3030

Later onset COPD, excluding more controls

525

1068

3.89

157.68

6.6

2.6

7.95

8.66

kpa

16.44

513

1041

Other nutritional deficiencies

1375

5799

2.21

155.19

5.3

3.6

8.60

8.79

kpa

3.63

1349

5668

Antihypertensive medication - note that there are other indications

1000

1945

2.73

154.69

4.7

2.5

9.13

9.15

kpa

0.14

984

1893

Infections, IBD-co-morbidities

352

471

5.42

153.12

7.9

3.1

8.83

8.75

kpa

0.28

341

462

Asthma, hospital admission 2, infections

1320

5960

2.20

149.94

5.0

3.8

8.62

8.70

kpa

0.91

1295

5802

Asthma-related infections

1320

5960

2.20

149.94

5.0

3.8

8.62

8.70

kpa

0.91

1295

5802

Alcohol use disorder, Swedish definition

1241

5077

2.27

149.51

4.7

4.0

8.54

8.66

kpa

1.60

1211

4968

Other diseases of blood and blood-forming organs, wide

608

1949

3.25

149.33

5.1

4.1

8.55

8.64

kpa

0.52

595

1911

Obesity due to excess calories

1016

4234

2.45

149.13

5.3

3.5

8.59

8.82

kpa

4.45

995

4151

Chronic lower respiratory diseases

2293

6523

1.88

147.82

4.8

3.5

8.55

8.79

kpa

7.83

2250

6362

Other arrhythmias

1137

3627

2.38

147.48

3.7

3.1

8.70

8.85

kpa

1.88

1111

3543

Ischaemic heart disease, wide definition

1520

4458

2.14

145.41

4.8

3.7

8.52

8.62

kpa

1.25

1490

4352

COPD, hospital admissions 3, with asthma pneumonia sepsis

765

2379

2.86

145.09

7.7

3.8

7.90

8.48

kpa

19.44

744

2317

Hyperlipidaemia, other/unspecified

946

3445

2.54

144.86

4.7

3.7

8.55

8.50

kpa

0.41

925

3360

Oedema, not elsewhere classified

697

2381

2.93

144.85

4.9

3.6

8.48

8.63

kpa

1.27

678

2320

Intracranial injury

1297

5624

2.19

144.35

4.0

8.54

8.67

kpa

1.83

1266

5485

Iron deficiency anaemia

1023

4259

2.42

143.85

5.7

3.8

8.41

8.58

kpa

2.30

1005

4151

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1033

4396

2.39

141.79

4.6

4.1

8.54

8.69

kpa

2.22

1008

4306

Alcohol use disorder, ICD-based

971

4073

2.45

140.88

4.5

4.1

8.54

8.70

kpa

2.06

947

3990

Disorders of gallbladder, biliary tract and pancreas

1933

6337

1.93

140.29

4.5

3.9

8.67

8.59

kpa

1.05

1884

6189

Constipation

1796

6308

1.96

139.42

4.6

3.9

8.57

8.63

kpa

0.69

1747

6164

Type 2 diabetes, definitions combined

1738

5147

1.99

136.97

4.3

3.3

8.65

8.68

kpa

0.26

1696

5029

Nutritional anaemias

1138

4908

2.26

136.82

5.6

3.8

8.41

8.55

kpa

1.73

1119

4779

Myocardial infarction

1017

2988

2.43

135.27

5.5

3.6

8.43

8.58

kpa

1.64

994

2909

Neurological diseases

1510

3635

2.11

134.04

4.2

3.7

8.88

8.74

kpa

1.87

1483

3553

Conduction disorders

644

1756

3.02

134.04

5.0

3.3

8.44

8.66

kpa

2.49

632

1716

980

4184

2.37

133.54

4.7

3.7

8.67

8.78

kpa

1.10

963

4073

Type 2 diabetes, strict (exclude DM1)

1744

5220

1.97

133.41

4.3

3.4

8.64

8.69

kpa

0.46

1702

5102

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

538

736

3.72

133.01

4.2

3.1

8.88

8.91

kpa

0.09

529

707

Acute upper respiratory infections of multiple and unspecified sites

1521

5554

2.03

132.49

4.4

3.8

8.80

8.70

kpa

1.23

1484

5420

Injuries to the head

2134

7011

1.83

131.07

4.0

3.9

8.66

8.72

kpa

0.86

2086

6841

Obesity

1253

5631

2.13

130.72

5.5

3.6

8.58

8.80

kpa

4.51

1225

5509

Obesity and other hyperalimentation

1256

5653

2.13

129.98

5.5

3.6

8.58

8.80

kpa

4.30

1228

5531

Abnormal spermatozoa

422

1181

3.80

129.79

4.0

4.9

8.38

8.53

kpa

1.00

412

1148

Codes for special purposes

1168

5431

2.18

129.13

5.2

3.8

8.60

8.67

kpa

0.63

1154

5292

Provisional assignment of new diseases of uncertain etiology

1167

5428

2.18

128.95

5.2

3.8

8.60

8.67

kpa

0.64

1153

5289

Type 1 diabetes, wide definition, subgroup 1

483

1467

3.40

128.84

6.2

3.6

8.67

8.87

kpa

1.61

469

1439

Asthma-related pneumonia

890

3742

2.43

127.48

6.0

3.9

8.43

8.58

kpa

1.88

873

3639

Major coronary heart disease event excluding revascularizations

1212

3701

2.20

127.17

5.1

3.6

8.49

8.57

kpa

0.78

1186

3604

Asthma-related pneumonia or sepsis

890

3750

2.43

126.86

6.0

3.9

8.43

8.59

kpa

1.90

873

3647

Asthma, hospital admissions 3, pneumonia

890

3750

2.43

126.86

6.0

3.9

8.43

8.59

kpa

1.90

873

3647

Symptoms and signs involving the digestive system and abdomen

1825

4800

1.93

126.68

4.3

3.8

8.81

8.62

kpa

4.10

1788

4675

Type 2 diabetes, definitions combined, including avohilmo

1718

5179

1.94

126.22

4.3

3.4

8.65

8.70

kpa

0.40

1675

5063

Gout

742

2446

2.69

125.97

6.4

4.1

8.46

8.41

kpa

0.32

729

2377

STROKE

961

2725

2.42

125.60

4.5

3.0

8.50

8.78

kpa

5.26

936

2665

Hypokalaemia

367

956

4.03

124.43

5.1

3.7

8.46

8.45

kpa

0.02

355

939

All influenza

584

2026

2.96

124.15

6.6

2.9

8.64

8.82

kpa

1.57

568

1977

Other respiratory diseases principally affecting the interstitium

528

1742

3.17

123.85

7.2

4.1

8.25

8.45

kpa

1.85

518

1694

Polyarthropathies

1362

4268

2.08

123.77

5.4

3.8

8.52

8.70

kpa

3.18

1340

4152

Personality disorders, excluding more controls

505

1612

3.20

123.40

4.5

3.4

8.94

8.96

kpa

0.09

483

1583

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

629

2283

2.83

122.92

4.2

3.6

9.04

8.87

kpa

1.36

605

2248

Mood disorders, excluding more controls

1703

5265

1.93

122.39

4.5

3.6

8.78

8.71

kpa

0.78

1655

5159

COPD-related respiratory insufficiency

380

1032

3.89

121.76

11.5

4.3

7.71

8.46

kpa

14.87

371

1009

Abnormalities of heart beat

706

2640

2.65

121.27

3.8

3.5

8.71

8.66

kpa

0.31

684

2571

Suicide or other Intentional self-harm

568

1972

2.97

120.87

4.3

3.8

8.95

8.81

kpa

0.96

547

1939

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1379

6081

2.01

120.60

5.4

3.8

8.40

8.58

kpa

4.09

1356

5925

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

1929

6860

1.83

120.13

4.8

3.7

8.74

8.67

kpa

0.87

1884

6696

Type 1 diabetes

558

1925

2.98

119.56

6.3

3.5

8.71

8.84

kpa

0.86

536

1885

Pain in limb

1642

5505

1.92

119.35

4.7

3.9

8.65

8.69

kpa

0.41

1609

5354

Other interstitial pulmonary diseases

465

1457

3.35

119.23

6.8

4.2

8.25

8.45

kpa

1.65

456

1423

Type 1 diabetes, wide definition

495

1603

3.18

118.70

6.2

3.6

8.68

8.86

kpa

1.38

481

1572

Interstitial lung disease endpoints

465

1461

3.34

118.70

6.8

4.3

8.25

8.45

kpa

1.62

456

1427

Interstitial lung disease

465

1461

3.34

118.70

6.8

4.3

8.25

8.45

kpa

1.62

456

1427

Other and unspecified iron deficiency

800

3319

2.47

118.50

5.6

3.7

8.40

8.58

kpa

2.10

788

3234

Neurological diseases, wide definition

483

673

3.67

116.98

3.7

2.8

9.17

8.98

kpa

1.03

473

656

Lung cancer and mesothelioma

425

1045

3.56

116.92

4.9

2.7

8.13

8.75

kpa

11.32

417

1021

Cardiodefibrillation

853

3669

2.39

116.63

4.6

4.3

8.38

8.45

kpa

0.63

841

3580

Abdominal and pelvic pain

1783

4800

1.89

116.29

4.2

3.8

8.78

8.62

kpa

2.98

1745

4675

Complications of procedures, not elsewhere classified

1553

6659

1.91

115.49

5.2

3.7

8.71

8.63

kpa

0.92

1528

6486

ILD, hospital admissions

456

1443

3.32

115.06

6.6

4.4

8.25

8.46

kpa

1.66

447

1409

Diseases of the respiratory system

1021

2218

2.34

114.96

4.7

2.5

8.63

8.96

kpa

5.65

1005

2166

Explicit bacterial Sepsis

297

703

4.42

114.48

6.8

2.9

8.42

8.67

kpa

1.48

289

691

Haemorrhage from respiratory passages

723

2546

2.57

114.39

5.5

3.7

8.41

8.52

kpa

0.93

710

2477

Other reaction to severe stress, and adjustment disorders

711

2849

2.55

113.40

4.7

3.5

9.00

8.88

kpa

0.97

697

2796

Other (not insulin) diabetes medications

1763

5659

1.85

112.55

4.5

3.4

8.60

8.66

kpa

0.63

1713

5529

Intestinal infectious diseases, including avohilmo, including avohilmo

2122

6817

1.75

112.09

4.8

3.7

8.70

8.66

kpa

0.44

2072

6655

Explicit bacterial Sepsis, including avohilmo

298

720

4.33

111.78

6.7

2.9

8.42

8.67

kpa

1.53

290

708

Other soft tissue disorders, not elsewhere classified

1795

5617

1.84

111.70

4.3

3.9

8.71

8.70

kpa

0.08

1761

5466

Autoimmune diseases

2006

5746

1.79

111.55

4.5

3.6

8.68

8.72

kpa

0.50

1962

5610

AV-block

430

1111

3.41

111.11

5.4

3.5

8.30

8.55

kpa

2.11

421

1081

Any mental disorder

1927

5387

1.81

110.74

4.4

3.7

8.61

8.69

kpa

1.08

1875

5278

Hydronephrosis

311

786

4.14

109.86

5.4

3.5

9.00

8.52

kpa

3.85

303

771

Ill-defined and unknown causes of mortality

342

937

3.87

108.46

5.3

4.8

8.30

8.31

kpa

0.03

332

915

Other ill-defined and unspecified causes of mortality

324

856

4.03

108.41

5.2

5.0

8.31

8.32

kpa

0.03

314

837

Problems related to lifestyle

285

682

4.36

108.25

5.4

3.2

8.69

8.81

kpa

0.50

274

672

Gout, unspecified

566

2089

2.82

108.12

6.9

4.2

8.43

8.48

kpa

0.25

555

2039

Gout, strict definition

518

1828

2.96

107.83

6.8

4.2

8.46

kpa

0.01

509

1782

Gout, FINNGEN

742

3098

2.45

107.60

6.4

4.0

8.46

8.42

kpa

0.27

729

3016

Diabetic maculopathy, excluding more controls

312

804

4.07

107.45

6.9

4.0

8.64

8.58

kpa

0.26

300

791

Acute alcohol intoxication, ICD10

507

1769

2.97

107.24

4.4

4.1

8.71

8.78

kpa

0.32

488

1737

Gout, idiopatic and unspecified

657

2624

2.59

106.85

6.7

4.1

8.41

8.47

kpa

0.38

645

2560

Schizophrenia or delusion, excluding more controls

590

2195

2.71

106.78

4.6

3.5

8.70

8.82

kpa

0.84

568

2156

Hyperkalaemia

228

465

5.27

106.55

8.5

4.0

8.45

8.33

kpa

0.36

223

455

Diseases of arteries, arterioles and capillaries

1367

5234

1.95

106.24

5.6

3.8

8.40

8.54

kpa

2.19

1336

5109

Early onset COPD

535

1932

2.87

106.22

6.9

3.8

8.15

8.69

kpa

11.68

524

1893

Complications of medical and surgical care

1428

6884

1.89

105.89

5.2

3.8

8.75

8.60

kpa

2.35

1405

6710

Used for control exclusion in common control thyroid runs

1877

5330

1.80

104.98

4.5

3.6

8.74

8.72

kpa

0.16

1836

5206

Autoimmune diseases excluding thyroid diseases

1862

5724

1.78

103.56

4.7

3.6

8.66

8.72

kpa

0.79

1819

5589

COPD, hospital admissions 1, only main diagnosis

819

3107

2.33

102.94

7.1

3.9

7.94

8.47

kpa

17.97

799

3033

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1124

4372

2.05

102.59

5.7

3.8

8.34

8.51

kpa

2.74

1087

4276

Diseases of the digestive system

1002

4825

2.10

101.64

6.1

3.9

8.60

8.52

kpa

0.60

982

4700

Unspecified kidney failure

307

816

3.95

101.29

8.3

3.7

8.61

8.39

kpa

1.14

299

799

Fall on same level

2029

6332

1.73

100.75

4.3

3.8

8.65

8.79

kpa

2.91

1983

6183

Autoimmune diseases excluding thyroid diseases, strict definition

1789

5524

1.78

99.33

4.7

3.6

8.66

8.73

kpa

0.91

1749

5396

Streptococcal septicaemia

263

636

4.35

98.87

6.9

4.0

8.41

8.51

kpa

0.43

256

624

Mood disorders

1840

6819

1.74

98.69

4.6

3.8

8.82

8.70

kpa

1.95

1787

6670

Mood [affective] disorders

1835

6815

1.74

98.33

4.6

3.8

8.82

8.70

kpa

2.05

1782

6666

Other disorders of urethra and urinary system

1303

4765

1.93

97.86

4.8

3.8

8.66

8.64

kpa

0.15

1273

4656

Use of hypnotics and sedatives

1913

6388

1.73

97.35

4.3

3.9

8.63

8.68

kpa

0.55

1874

6236

Exclusions for E4_PCOS_BROAD

425

1420

3.10

97.05

5.6

4.3

8.60

8.79

kpa

1.36

418

1397

Depression or dysthymia

1176

3205

2.03

96.57

4.3

3.7

8.77

8.67

kpa

0.97

1150

3142

Streptococcal septicaemia, including avohilmo

264

652

4.25

96.47

6.9

4.0

8.41

8.53

kpa

0.53

257

639

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

457

1598

2.96

96.43

3.8

4.2

8.98

8.41

kpa

6.53

451

1556

Drug-induced neutropenia

235

537

4.67

95.60

3.9

4.7

8.64

8.55

kpa

0.30

230

530

Anxiety disorders, excluding more controls

1396

4803

1.88

95.44

4.6

3.6

8.87

8.76

kpa

1.52

1361

4707

Epilepsy

625

2553

2.49

95.38

4.4

3.9

8.65

8.59

kpa

0.43

604

2491

Selective serotonin reuptake inhibitors

1737

5136

1.78

94.82

4.0

3.8

8.75

8.68

kpa

0.74

1686

5031

ILD, hospital admissions 1, main diag only

392

1276

3.22

94.41

6.7

4.5

8.25

8.43

kpa

1.16

385

1249

Symptoms and signs involving the nervous and musculoskeletal systems

1145

5974

1.95

94.37

4.5

3.9

8.76

8.61

kpa

2.30

1130

5819

Depression

1689

6492

1.76

94.13

4.4

3.7

8.87

8.73

kpa

2.53

1639

6351

Asthma (diagnoses ohter than nonallergic)

1618

7500

1.76

94.13

4.5

3.8

8.61

8.71

kpa

1.35

1589

7310

Angina pectoris

1009

3248

2.10

94.06

4.6

3.6

8.56

8.60

kpa

0.32

994

3160

Persons encountering health services for specific procedures, not carried out

244

579

4.42

93.93

5.6

3.4

8.89

8.76

kpa

0.51

239

567

Other diseases of urinary system

1758

5696

1.75

93.03

4.5

3.9

8.67

8.66

kpa

0.02

1713

5572

Symptoms and signs involving the urinary system

1455

6117

1.82

92.50

4.5

4.0

8.60

8.61

kpa

0.09

1413

5979

Glomerulonephritis

294

810

3.83

92.34

9.1

4.5

9.13

8.51

kpa

7.10

286

797

Implicit fungal Sepsis, including avohilmo

207

442

4.94

91.17

9.4

2.8

8.40

8.72

kpa

1.61

202

437

Hypertensive heart and/or renal disease

527

1434

2.75

90.95

6.4

3.3

8.22

8.53

kpa

3.56

516

1403

Acute alcohol intoxication

583

2374

2.52

90.63

4.7

4.3

8.59

8.69

kpa

0.57

561

2325

Lung diseases due to external agents

395

1321

3.12

90.57

6.2

4.6

8.08

8.36

kpa

3.05

383

1292

Malignant neoplasm

1448

4671

1.84

90.54

4.1

3.9

8.74

8.65

kpa

1.10

1428

4549

Other symptoms and signs involving the nervous and musculoskeletal systems

834

3952

2.15

90.18

4.6

3.9

8.75

8.65

kpa

0.93

823

3860

Substance use, excluding alcohol

436

1541

2.91

89.92

5.0

3.9

8.67

8.88

kpa

1.64

421

1517

Alcohol dependence

594

2461

2.48

88.96

4.8

4.2

8.50

8.66

kpa

1.35

576

2409

Cardiomyopathy

370

1201

3.17

88.69

5.6

3.3

8.20

8.73

kpa

5.91

363

1172

Retention of urine

787

2927

2.23

88.39

4.8

4.2

8.38

8.45

kpa

0.54

762

2859

Malignant neoplasm, wide definition

1466

4755

1.82

88.14

4.3

3.8

8.73

8.66

kpa

0.70

1444

4631

Diabetic nephropathy, excluding more controls

443

1274

2.96

88.07

9.0

3.5

8.45

8.71

kpa

2.34

434

1239

Diseases of liver

740

3383

2.24

87.96

5.1

4.0

8.62

8.63

kpa

0.01

718

3312

Biguanides

1678

5892

1.74

87.95

4.3

3.6

8.59

8.67

kpa

0.93

1627

5758

Certain infectious and parasitic diseases, including avohilmo

1170

2995

1.98

87.87

4.9

3.0

8.66

8.77

kpa

1.09

1149

2921

Other functional intestinal disorders

923

4138

2.06

87.85

4.7

3.8

8.66

8.59

kpa

0.58

899

4034

Myocardial infarction, strict

857

2859

2.16

87.61

5.4

3.6

8.41

8.56

kpa

1.59

836

2783

Malignant neoplasm

1436

4670

1.82

87.48

4.2

3.9

8.75

8.65

kpa

1.28

1416

4548

Malignant neoplasm, including Hilmo

1459

4748

1.81

86.95

4.2

3.8

8.74

8.67

kpa

0.76

1437

4624

Diagnoses used for exclusion with ILD

594

2490

2.45

86.80

5.3

4.1

8.21

8.54

kpa

5.50

582

2425

Spondylosis

1079

4391

1.95

85.67

3.6

4.1

8.58

8.55

kpa

0.17

1061

4283

Osteopathies and chondropathies

1089

5253

1.93

85.46

5.6

3.7

8.53

8.65

kpa

1.41

1072

5120

Cholelithiasis, broad definition with cholecystitis

1535

5888

1.76

84.89

4.1

3.9

8.59

8.55

kpa

0.35

1499

5747

Chronic pancreatitis

330

1042

3.30

83.54

6.0

4.2

9.15

8.52

kpa

5.83

325

1016

Myocardial infarction, without ST-elevation

888

3978

2.06

83.50

5.6

4.1

8.33

8.40

kpa

0.56

870

3869

Other or unspecified ileus, impaction or obstruction

457

1738

2.71

82.03

5.2

3.9

8.78

8.50

kpa

2.16

448

1691

Alcohol abuse, main dg, excluding more controls

331

1057

3.23

81.77

4.8

4.0

8.67

8.78

kpa

0.49

319

1044

Disorders of mineral metabolism

247

660

3.93

81.04

5.7

4.0

8.78

8.51

kpa

1.42

239

650

Solid cancers, including Hilmo

1417

4675

1.79

80.88

4.1

3.8

8.77

8.65

kpa

1.53

1396

4553

Liquid cancers, including Hilmo

716

2917

2.21

80.76

4.6

4.1

8.46

8.47

kpa

0.06

702

2838

Other diseases of intestines

1806

6095

1.67

79.98

4.5

3.7

8.76

8.73

kpa

0.25

1768

5947

ILD medications: azathioprine

315

993

3.27

79.50

7.0

3.3

9.10

8.85

kpa

1.42

309

975

Chronic apical periodontitis

1934

6701

1.63

79.46

4.2

3.8

8.74

8.69

kpa

0.52

1886

6546

Low back pain

1400

5413

1.77

79.38

4.3

3.9

8.65

8.71

kpa

0.69

1365

5279

Psychiatric diseases

1604

4700

1.73

78.82

4.4

3.8

8.70

8.67

kpa

0.21

1567

4603

Infections of the skin and subcutaneous tissue

1097

5883

1.86

78.76

5.6

3.8

8.74

8.71

kpa

0.21

1079

5746

Osteoporosis

589

2342

2.37

78.72

5.2

3.9

8.41

8.45

kpa

0.20

578

2282

Paralytic ileus and intestinal obstruction

582

2528

2.36

78.18

5.1

3.8

8.72

8.53

kpa

1.54

569

2460

Cholelithiasis

1460

5807

1.74

78.11

4.1

3.8

8.60

8.55

kpa

0.54

1426

5668

Emphysema

226

587

4.06

77.34

7.5

4.3

7.75

8.52

kpa

10.95

221

572

Personality disorders

505

2069

2.49

77.31

4.5

3.7

8.94

kpa

0.02

483

2032

Solid cancers

1375

4591

1.78

77.10

4.1

3.9

8.75

8.64

kpa

1.39

1356

4470

Acute upper respiratory infections

1806

6652

1.64

76.91

4.1

3.8

8.69

8.64

kpa

0.41

1764

6491

Other disorders of bladder

316

1022

3.22

76.86

4.0

4.5

8.49

8.52

kpa

0.12

304

1000

Azathioprine

315

1017

3.19

76.40

7.0

3.5

9.10

8.86

kpa

1.38

309

1000

Diseases of oesophagus, stomach and duodenum

1839

6718

1.63

76.02

4.6

3.7

8.66

8.68

kpa

0.19

1800

6547

Pain, not elsewhere classified

468

1864

2.56

75.90

4.7

3.5

8.81

8.73

kpa

0.44

456

1823

Agranulocytosis

288

888

3.38

75.87

4.4

4.3

8.66

8.59

kpa

0.28

283

871

Genitourinary diseases

956

2413

2.01

75.08

5.4

3.0

8.89

8.76

kpa

1.19

934

2352

Sequelae with surgical and medical care as external cause

470

1894

2.56

75.05

4.8

4.1

8.43

8.59

kpa

1.09

461

1856

Anxiety disorders

1504

6139

1.70

74.59

4.6

3.7

8.91

8.74

kpa

3.03

1466

6002

Accidents

1298

3647

1.80

73.70

4.3

3.7

8.70

8.76

kpa

0.46

1274

3557

Disorders of lens

1167

3998

1.83

73.56

5.6

3.8

8.49

8.59

kpa

1.19

1141

3906

Other diseases of the digestive system

712

3441

2.12

73.50

6.4

4.0

8.48

8.49

kpa

0.04

697

3346

Neurotic, stress-related and somatoform disorders

1482

6084

1.70

73.13

4.5

3.7

8.90

8.74

kpa

2.73

1444

5949

GI-bleeding

713

3455

2.11

73.04

6.5

3.9

8.49

8.48

kpa

0.03

699

3355

Any event in cancer register

1477

5093

1.71

72.86

4.0

3.9

8.76

8.70

kpa

0.61

1457

4960

Falls/tendency to fall

1759

5401

1.65

72.68

4.2

3.8

8.66

8.81

kpa

2.52

1722

5276

Valvular operations

300

972

3.18

72.37

5.4

3.5

8.16

8.67

kpa

4.72

292

945

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1115

6154

1.80

72.00

5.2

3.7

8.81

8.57

kpa

4.09

1097

6005

Other external causes of accidental injury

1290

3647

1.79

71.78

4.3

3.7

8.70

8.76

kpa

0.42

1262

3557

Asthma/COPD (KELA code 203)

1598

6514

1.65

71.68

4.8

3.5

8.56

8.79

kpa

6.26

1570

6353

Cardiomyopathies, Primary/intrinsic

268

818

3.39

71.50

5.5

3.5

8.13

8.76

kpa

5.44

263

795

Cardiomyopathy (excluding other)

276

858

3.33

71.46

5.4

3.5

8.12

8.75

kpa

5.66

271

834

Disorders of adult personality and behaviour

517

2222

2.37

71.14

4.4

3.6

8.95

8.97

kpa

0.09

495

2180

Open wound of head

1049

5465

1.83

70.72

4.3

4.1

8.51

8.63

kpa

1.50

1020

5338

Hypothyroidism, strict autoimmune

1232

4610

1.77

70.60

4.2

3.6

8.65

8.68

kpa

0.29

1203

4500

Sub-endpoint used in defining T1D endpoints

592

2658

2.24

70.45

6.4

4.0

8.65

8.72

kpa

0.46

568

2600

Anxiety (asthma-related co-morbidities)

938

3772

1.91

70.43

3.8

3.6

8.98

8.87

kpa

1.04

908

3702

Kela-code for severe mental illness

666

3187

2.13

70.35

4.7

3.8

8.70

8.80

kpa

0.74

642

3118

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

570

2572

2.26

69.98

4.4

3.8

8.55

8.71

kpa

1.56

558

2525

Glucagon-like peptide-1 (GLP-1) analogues

570

2572

2.26

69.98

4.4

3.8

8.55

8.71

kpa

1.56

558

2525

Unspecified fall

991

5350

1.85

69.26

4.5

4.0

8.56

8.66

kpa

0.90

968

5217

Schizophrenia, schizotypal and delusional disorders

596

2759

2.20

68.65

4.7

3.8

8.71

8.81

kpa

0.67

574

2706

Disorders of parathyroid gland

444

1795

2.51

68.40

7.0

3.7

8.70

8.44

kpa

2.17

439

1747

Coagulation defects, purpura and other haemorrhagic conditions

424

1705

2.56

67.94

5.5

4.2

8.62

kpa

0.02

413

1673

Intestinal stricture

650

3138

2.12

67.35

5.6

4.0

8.77

8.50

kpa

3.00

638

3059

Diseases of pulp and periapical tissues, including avohilmo

1743

5639

1.61

67.01

4.0

3.9

8.75

8.67

kpa

1.08

1696

5512

Noninfective enteritis and colitis

852

4516

1.91

66.92

4.6

3.9

8.80

8.73

kpa

0.57

835

4406

Schizophrenia or delusion

590

2750

2.19

66.81

4.6

3.8

8.70

8.81

kpa

0.73

568

2697

Sequelae of external causes of morbidity and mortality

545

2466

2.26

66.71

5.0

4.0

8.48

8.62

kpa

1.03

535

2411

Specific personality disorders

432

1765

2.50

66.65

4.4

3.8

8.88

8.95

kpa

0.35

412

1737

Other noninfective gastroenteritis and colitis

505

2219

2.33

66.09

4.8

4.0

8.80

8.68

kpa

0.71

500

2171

Disorders of calcium metabolism

185

466

4.18

66.08

6.0

4.0

8.74

8.44

kpa

1.36

179

459

Symptoms and signs involving cognition, perception, emotional state and behaviour

1660

6976

1.61

65.93

4.2

3.9

8.67

8.68

kpa

0.07

1610

6824

Unspecified mental disorder

709

3554

2.03

65.89

4.6

3.8

8.74

8.83

kpa

0.63

685

3479

Other cataract

805

3076

1.98

65.88

5.2

3.8

8.45

8.55

kpa

0.87

784

3000

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

189

486

4.07

65.47

4.3

3.5

8.90

9.20

kpa

1.51

182

478

Other anxiety disorders

762

3306

1.99

65.35

3.9

3.5

9.04

8.89

kpa

1.37

739

3245

Other retinal disorders

1208

5374

1.73

65.18

5.0

4.0

8.54

kpa

0.00

1175

5251

Autoimmune diseases related-to ILD

1435

7376

1.64

64.78

4.2

3.8

8.65

8.72

kpa

0.79

1404

7195

Disorders of choroid and retina

1443

6188

1.65

64.54

4.8

3.9

8.58

8.56

kpa

0.13

1400

6047

Liquid cancers

573

2528

2.19

64.27

4.9

4.2

8.45

8.44

kpa

0.05

563

2457

Gastrointestinal diseases

881

2288

1.95

63.78

4.5

2.9

8.88

8.80

kpa

0.50

865

2222

External causes of morbidity and mortality

1005

2730

1.86

63.69

4.3

3.6

8.72

8.76

kpa

0.25

988

2657

Recurrent or chronic depression

609

1970

2.17

63.56

3.4

8.99

8.85

kpa

1.06

593

1930

Non-allergic asthma (mode), excluding more controls

283

953

3.00

62.37

5.4

2.4

8.61

9.11

kpa

3.97

278

932

Cystitis

1388

5010

1.66

62.19

4.2

3.8

8.68

8.65

kpa

0.24

1343

4897

Spondylopathies

1365

4879

1.67

62.10

3.8

4.0

8.57

8.60

kpa

0.24

1336

4758

Other CVD

477

2115

2.32

61.53

4.7

4.2

8.47

8.36

kpa

0.67

464

2056

Senile cataract

1055

3627

1.79

61.46

5.3

3.9

8.42

8.55

kpa

1.65

1033

3541

Fluid overload

38.25

61.39

14.3

2.4

8.75

8.66

kpa

0.04

Asthma, including avohilmo

1984

7209

1.53

61.34

4.3

3.9

8.65

8.71

kpa

0.75

1945

7026

Cough

639

2942

2.05

61.21

4.1

3.5

8.74

8.69

kpa

0.25

625

2869

Peripheral artery disease

856

3666

1.88

60.62

6.5

4.0

8.24

8.41

kpa

2.01

832

3575

Iron deficiency anaemia secondary to blood loss (chronic)

363

1434

2.61

60.54

5.8

4.0

8.46

8.49

kpa

0.11

354

1401

Later onset COPD

624

2456

2.09

59.79

6.4

3.8

7.93

8.39

kpa

10.22

605

2391

Emotionally unstable personality disorder

238

755

3.24

59.54

4.7

3.3

9.02

9.14

kpa

0.41

225

742

Malignant neoplasm of digestive organs

723

2845

1.98

59.52

4.5

4.1

8.94

8.42

kpa

7.69

711

2767

Acute pancreatitis

409

1728

2.43

58.90

5.7

4.1

8.81

8.57

kpa

1.82

398

1684

Malignant neoplasm of digestive organs, including Hilmo

773

2995

1.93

58.80

4.5

4.2

8.94

8.43

kpa

7.67

761

2911

Other and unspecified nonorganic psychotic disorders

368

1484

2.54

58.54

4.4

3.8

8.80

8.98

kpa

1.20

354

1459

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1616

6553

1.57

58.43

4.7

3.8

8.56

8.64

kpa

1.06

1589

6383

Hypothyreosis and Thyroxine purchase for inclusion criteria

1520

6312

1.59

58.25

4.2

3.8

8.64

8.66

kpa

0.14

1482

6166

Hypertensive Heart Disease

427

1363

2.42

58.19

6.0

3.4

8.14

8.51

kpa

4.52

420

1333

Thrombocytopenia, unspecified

204

602

3.56

57.93

5.8

4.6

8.70

8.43

kpa

1.31

197

593

Hypothyroidism, other/unspecified

1465

6064

1.60

57.86

4.2

3.8

8.65

kpa

0.01

1431

5924

Injuries to the thorax

882

4954

1.81

57.74

4.4

4.1

8.42

8.60

kpa

2.75

856

4834

Unspecified haematuria

829

3694

1.86

57.32

5.0

4.2

8.53

8.48

kpa

0.32

808

3605

Disorders of the thyroid gland

1568

6518

1.57

57.26

4.2

3.9

8.70

8.64

kpa

0.56

1532

6370

Abnormal results of function studies

218

676

3.35

56.97

5.9

4.3

8.32

8.67

kpa

2.04

212

665

Dental caries

491

2131

2.22

56.95

7.6

3.9

8.71

8.66

kpa

0.24

485

2084

Finngen Rheumatological endpoints

1539

5547

1.59

56.85

4.3

3.7

8.66

8.77

kpa

1.63

1513

5396

Caries of dentine

446

1907

2.30

56.84

7.8

3.9

8.67

8.66

kpa

0.03

440

1866

Delirium, not induced by alcohol and other psychoactive substances

320

1225

2.70

56.84

5.6

4.7

8.19

8.40

kpa

1.26

308

1191

All anxiety disorders

968

4304

1.76

56.50

3.8

3.6

8.99

8.85

kpa

1.54

938

4213

Hypotension

424

1858

2.35

56.36

4.7

4.3

8.47

8.32

kpa

0.98

412

1805

Second line medication for Crohn's disease

966

5610

1.74

56.04

4.9

3.8

8.71

8.72

kpa

0.08

951

5480

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1011

5945

1.72

55.80

5.4

3.8

8.81

8.57

kpa

3.80

995

5802

Acute sinusitis

834

4209

1.82

55.77

4.1

3.7

8.79

kpa

0.00

820

4118

Diabetic nephropathy

446

1987

2.30

55.65

9.0

4.2

8.45

8.56

kpa

0.66

437

1926

Other headache syndromes

632

3218

1.98

55.56

3.7

3.6

8.95

8.72

kpa

2.43

614

3143

Abnormal findings on diagnostic imaging of lung

899

4871

1.77

54.98

5.8

3.9

8.30

8.52

kpa

3.94

884

4744

Purpura and other haemorrhagic conditions

301

1138

2.73

54.97

5.3

4.4

8.62

8.53

kpa

0.41

293

1114

Dorsalgia

1620

5547

1.56

54.70

3.9

8.73

8.72

kpa

0.11

1587

5408

Aortic aneurysm

501

2335

2.15

54.11

4.3

4.2

8.32

8.41

kpa

0.54

490

2280

L04AX Other immunosuppressants

936

5447

1.74

54.04

5.0

3.8

8.68

8.71

kpa

0.17

923

5323

Asthma, hospital admissions , main diagnosis only

1367

7572

1.58

54.03

4.3

3.8

8.71

kpa

0.00

1347

7375

Presbycusis

353

1434

2.51

54.03

3.8

4.5

8.41

8.24

kpa

1.19

347

1384

Urinary track infection

799

2139

1.89

52.98

3.7

2.9

8.82

8.85

kpa

0.12

785

2090

Other diseases of biliary tract

217

703

3.21

52.80

5.3

4.4

8.90

8.38

kpa

3.44

211

689

Other complications of surgical and medical care, not elsewhere classified

221

723

3.16

52.75

4.9

3.9

8.68

8.54

kpa

0.60

221

711

Alcohol abuse, main dg

331

1340

2.54

52.48

4.8

4.2

8.67

8.78

kpa

0.50

319

1315

Diseases of the myoneural junction and muscle

286

1081

2.74

52.39

5.4

4.6

8.58

8.45

kpa

0.55

277

1057

Mental and behavioural disorders due to sedatives or hypnotics

170

477

3.72

52.03

5.4

3.9

8.56

8.89

kpa

1.67

163

470

Diabetic retinopathy, excluding more controls

578

1575

2.11

52.00

5.8

3.6

8.55

8.74

kpa

1.93

561

1536

Atherosclerosis, excluding cerebral and coronary sclerosis

791

3457

1.83

51.61

6.4

4.0

8.28

8.39

kpa

1.05

765

3370

Other diseases of liver

367

1570

2.40

51.47

4.8

4.1

8.83

8.65

kpa

1.10

356

1547

Disorders of lipoprotein metabolism and other lipidaemias

1287

4899

1.61

51.31

4.5

3.6

8.55

8.63

kpa

0.89

1261

4782

Diseases of peritoneum

243

854

2.95

51.22

8.6

4.6

8.96

8.43

kpa

4.36

236

840

Dysphagia

457

2150

2.17

50.72

6.1

3.8

8.58

8.50

kpa

0.41

446

2097

Other and unspecified effects of external causes

482

2321

2.11

50.28

4.2

3.9

8.88

8.82

kpa

0.34

471

2274

Non-allergic asthma (mode)

283

1070

2.67

50.24

5.4

2.6

8.61

9.00

kpa

2.65

278

1043

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

470

1825

2.16

49.93

4.9

4.3

8.13

8.32

kpa

1.87

460

1776

Hypothyroidism, strict autoimmune, 3 medication purchases required

1343

5775

1.58

49.80

4.2

3.8

8.65

8.67

kpa

0.18

1304

5641

Symptoms and signs concerning food and fluid intake

204

656

3.19

49.78

5.1

4.0

8.89

8.58

kpa

1.34

198

639

Other and unspecified myopathies

221

754

3.05

49.23

5.0

4.8

8.53

8.41

kpa

0.38

213

739

Dermatitis

1071

6470

1.64

49.17

4.8

3.8

8.61

8.67

kpa

0.53

1056

6301

Acute pancreatitis (for exclusion)

409

1869

2.24

49.08

5.7

4.2

8.81

8.55

kpa

2.15

398

1823

Pneumonitis due to solids and liquids

220

750

3.05

49.08

6.8

4.8

8.06

8.30

kpa

1.44

212

736

Neoplasms

1141

3653

1.65

48.73

4.5

3.7

8.93

8.87

kpa

0.52

1122

3556

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

325

1360

2.46

48.13

5.3

4.6

8.56

8.53

kpa

0.09

315

1334

Calcific aortic valvular stenosis, including rheumatic fever

624

3209

1.91

48.06

5.3

4.2

8.27

8.36

kpa

0.62

610

3113

Calcific aortic valvular stenosis, operated

623

3211

1.91

47.84

5.3

4.2

8.27

8.36

kpa

0.64

609

3115

Calcific aortic valvular stenosis

623

3211

1.91

47.84

5.3

4.2

8.27

8.36

kpa

0.64

609

3115

Operations 2 for CAVS

622

3205

1.91

47.79

5.3

4.2

8.28

8.36

kpa

0.61

608

3109

Calcific aortic valvular stenosis, diagnosis (helper)

622

3205

1.91

47.79

5.3

4.2

8.28

8.36

kpa

0.61

608

3109

Lower back pain or/and sciatica

1755

7436

1.48

47.67

4.1

3.9

8.64

8.70

kpa

0.72

1717

7255

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

163

472

3.59

47.57

5.6

4.2

9.02

8.89

kpa

0.46

158

466

Certain disorders involving the immune mechanism

367

1629

2.31

47.29

5.3

4.1

8.81

8.67

kpa

0.88

361

1602

Injuries to the abdomen, lower back, lumbar spine and pelvis

749

4205

1.78

46.86

4.6

3.9

8.44

8.64

kpa

2.26

724

4103

Bacterial pneumoniae

631

2979

1.88

46.67

6.5

2.9

8.31

8.76

kpa

9.73

609

2910

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1611

5732

1.50

46.24

6.1

3.3

8.79

8.65

kpa

2.12

1582

5610

Cutaneous abscess, furuncle and carbuncle

472

2329

2.06

46.20

5.8

3.8

8.70

8.79

kpa

0.48

467

2285

Focal epilepsy

403

1878

2.19

45.94

4.4

8.65

8.71

kpa

0.23

393

1834

Care involving use of rehabilitation procedures

950

5191

1.66

45.90

4.5

3.1

8.77

8.65

kpa

1.29

932

5043

Elevated blood glucose level

203

689

3.06

45.63

6.2

4.7

8.59

8.57

kpa

0.07

197

679

Hypertension, Pulmonary Arterial

13.54

45.49

7.9

3.9

6.36

8.68

kpa

5.15

Dental pulpitis, including avohilmo

1410

5971

1.52

44.75

3.6

3.9

8.95

8.78

kpa

3.02

1375

5849

Migraine

660

2824

1.84

44.36

3.2

3.6

9.17

8.85

kpa

4.35

646

2769

Pain (limb, back, neck, head abdominally)

1127

3513

1.62

44.28

4.5

3.8

8.73

8.62

kpa

1.19

1104

3429

Cardiac arrest

120

241

4.35

44.05

5.4

3.0

8.53

8.75

kpa

0.52

115

234

Other arthritis (FG)

530

2785

1.93

43.25

5.4

3.8

8.47

8.67

kpa

1.66

525

2709

Supplementary factors related to causes of morbidity and mortality classified elsewhere

564

3029

1.89

43.09

4.9

3.9

8.60

8.75

kpa

1.21

549

2963

Malignant neoplasm of respiratory system and intrathoracic organs

416

1650

2.13

42.92

4.8

4.4

8.16

8.32

kpa

1.27

408

1605

Traumatic subdural haemorrhage

282

1088

2.48

42.41

4.6

4.3

8.18

8.45

kpa

2.01

276

1064

Protein-energy malnutrition of moderate and mild degree

9.72

42.32

5.0

3.8

8.42

8.19

kpa

0.31

Malignant neoplasm of bronchus and lung, including Hilmo

414

1661

2.12

42.11

5.0

4.4

8.10

8.31

kpa

2.06

407

1616

Other viral diseases

483

2476

1.97

41.94

5.9

3.9

9.02

8.89

kpa

0.90

473

2423

Factors influencing health status and contact with health services

463

1115

2.11

41.59

4.7

2.8

8.59

8.69

kpa

0.48

452

1088

Cellulitis

411

2006

2.09

41.58

6.3

3.9

8.81

8.69

kpa

0.67

405

1968

Other disorders of glucose regulation and pancreatic internal secretion

196

689

2.94

41.37

6.1

4.4

8.55

8.57

kpa

0.07

191

677

Lyme disease, including avohilmo

3317

0.25

41.29

3.4

3.9

8.83

8.69

kpa

0.36

3249

Lyme disease

3317

0.25

41.29

3.4

3.9

8.83

8.69

kpa

0.36

3249

Viral and other specified intestinal infections, including avohilmo

450

2181

2.01

41.22

6.2

3.3

9.20

8.95

kpa

1.92

440

2131

All influenza (not pneumonia)

256

1030

2.54

41.09

6.4

3.0

8.64

8.86

kpa

1.17

248

1004

Other diseases of pancreas

193

676

2.96

41.06

5.4

4.6

8.76

8.40

kpa

2.32

188

663

Other spirochaetal diseases

3338

0.25

41.05

3.4

3.9

8.82

8.70

kpa

0.31

3269

Other and unspecified dermatitis

873

5372

1.64

41.02

4.9

3.8

8.60

8.68

kpa

0.72

861

5233

Other spirochaetal diseases, including avohilmo

3380

0.26

40.92

3.3

3.9

8.84

8.70

kpa

0.40

3308

Other neurological diseases

1207

6155

1.54

40.86

4.2

4.1

8.58

8.55

kpa

0.22

1172

6012

Non-selective monoamine reuptake inhibitors

582

3074

1.84

40.70

4.9

3.6

8.33

8.62

kpa

3.54

565

3014

Cerebrovascular diseases

1237

5654

1.53

40.67

4.5

4.1

8.46

8.54

kpa

0.83

1199

5528

Spirochaetal infections, other/unspecified, including avohilmo

3335

0.25

40.66

3.3

3.9

8.86

8.70

kpa

0.47

3266

Focal epilepsy, strict definition

370

1754

2.15

40.48

4.3

4.4

8.65

8.67

kpa

0.08

361

1715

Viral infections characterized by skin and mucous membrane lesions

708

4150

1.73

40.05

5.2

3.9

8.78

8.68

kpa

0.73

703

4050

Hernia of abdominal wall

786

4747

1.68

39.92

5.0

4.0

8.67

8.59

kpa

0.61

766

4645

Other specified/unspecified arthritis

469

2439

1.95

39.57

5.5

3.9

8.51

8.68

kpa

1.16

464

2377

Nonorganic sleeping disorders, excluding more controls

310

1380

2.28

39.51

3.9

3.6

9.07

8.87

kpa

1.29

302

1360

Pneumonia due to Haemophilus influenzae

18.69

39.48

6.6

2.3

8.50

9.00

kpa

0.41

Injury, poisoning and certain other consequences of external causes

768

2230

1.74

39.47

4.3

3.7

8.66

8.76

kpa

0.72

755

2169

Viral and other specified intestinal infections

354

1628

2.16

39.01

7.0

3.4

9.16

8.96

kpa

1.17

346

1591

Pleural plaque

209

786

2.75

38.86

4.7

3.8

8.11

8.45

kpa

2.30

203

764

Focal epilepsy, mode (most common among epilepsy diagnosis)

351

1657

2.16

38.85

4.5

8.72

8.66

kpa

0.26

341

1621

Fracture of rib(s), sternum and thoracic spine

580

3256

1.81

38.51

4.1

8.29

8.57

kpa

4.13

562

3174

Dizziness and giddiness

1196

6182

1.52

38.50

4.0

8.65

8.62

kpa

0.30

1165

6047

Unstable angina pectoris

607

2689

1.80

37.99

4.5

3.8

8.63

8.45

kpa

1.63

596

2621

Diseases of the musculoskeletal system and connective tissue

806

2400

1.70

37.97

4.5

3.5

8.79

8.83

kpa

0.16

789

2333

Stroke, including SAH

1075

5018

1.55

37.89

4.6

4.1

8.43

8.52

kpa

0.81

1040

4903

Any operation in hilmo

23.33

37.73

3.1

1.2

8.86

8.50

kpa

—

Other disorders of skin and subcutaneous tissue

1186

6693

1.51

37.63

5.7

3.8

8.50

8.61

kpa

1.36

1171

6524

Bipolar affective disorders

289

1279

2.30

37.44

4.7

3.6

8.73

8.90

kpa

0.87

281

1258

Stroke, excluding SAH

1031

4811

1.56

37.41

4.6

4.1

8.41

8.50

kpa

0.89

1003

4697

Other specified and unspecified personality disorders

175

611

2.95

37.34

5.7

3.8

8.72

8.83

kpa

0.40

169

603

Internal derangement of knee

611

3477

1.76

37.15

4.1

3.9

8.77

8.70

kpa

0.44

603

3387

Gastro-oesophageal reflux disease

1087

6036

1.53

37.12

4.2

3.8

8.71

8.64

kpa

0.68

1068

5888

Soft tissue disorders

1586

5662

1.44

37.06

3.9

8.79

8.70

kpa

1.07

1563

5507

Diabetic retinopathy, strict definition

408

1836

2.03

36.91

6.7

4.4

8.57

8.65

kpa

0.49

395

1785

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

294

1278

2.28

36.84

6.3

4.5

8.92

8.80

kpa

0.51

287

1257

Transport accidents

674

3296

1.72

36.69

3.5

3.7

8.77

8.80

kpa

0.19

662

3218

Peripheral arterial reconstruction

358

1746

2.10

36.56

7.3

4.4

8.14

8.40

kpa

2.40

345

1701

Non-small cell lung cancer, including Hilmo

302

1287

2.25

36.50

4.7

4.3

8.14

8.34

kpa

1.37

297

1248

Fentanyl

203

775

2.68

36.31

6.2

4.2

8.72

8.32

kpa

1.81

195

748

Exclusions for E4_PCOS_CONSORTIUM

1022

4115

1.56

36.28

3.8

3.7

8.78

8.80

kpa

0.16

1000

4019

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

309

1383

2.21

36.20

6.1

4.5

8.92

8.80

kpa

0.49

302

1359

Primary_lymphoid and hematopoietic malignant neoplasms

455

2420

1.92

36.09

4.9

4.2

8.49

8.51

kpa

0.09

446

2362

Diseases of the skin and subcutaneous tissue

1519

5294

1.45

36.04

4.3

3.6

8.68

8.71

kpa

0.23

1492

5144

Diseases of the eye and adnexa

1158

3816

1.53

35.95

4.4

3.6

8.83

8.84

kpa

0.04

1135

3727

Alcoholic liver disease

220

884

2.57

35.78

5.4

4.9

8.59

8.49

kpa

0.32

211

868

Other bacterial intestinal infections

336

1613

2.12

35.66

7.8

3.8

8.60

8.54

kpa

0.21

325

1578

Malignant neoplasm of bronchus and lung

361

1474

2.09

35.42

4.8

4.3

8.13

8.32

kpa

1.54

356

1429

Hypoglycaemia, other or unspecified

158

545

3.00

34.64

5.3

4.6

8.54

8.59

kpa

0.12

153

536

Gastroduodenal ulcer

495

2742

1.83

34.08

5.8

4.1

8.40

8.45

kpa

0.27

486

2662

Other viral diseases, including avohilmo

574

3290

1.75

34.07

5.3

3.7

9.13

8.90

kpa

2.23

563

3218

Mixed and other personality disorders

152

517

3.03

34.05

5.7

3.7

9.05

8.93

kpa

0.33

146

509

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

846

4159

1.59

34.03

3.9

3.7

8.69

8.77

kpa

0.60

825

4069

Type of accident

502

2812

1.81

33.61

4.9

3.9

8.58

8.74

kpa

1.23

488

2747

Sensorineural hearing loss

1221

5560

1.48

33.59

4.0

4.2

8.52

8.53

kpa

0.11

1193

5433

Meniscus derangement

877

3715

1.58

33.15

3.8

3.9

8.57

8.61

kpa

0.33

862

3614

Other infectious diseases

170

627

2.80

32.93

6.9

4.7

8.07

8.48

kpa

2.56

163

616

Enterocolitis due to Clostridium difficile

227

961

2.43

32.92

8.4

4.3

8.56

8.39

kpa

0.68

217

941

Dorsopathies

1553

5580

1.42

32.92

3.9

8.81

8.73

kpa

0.91

1524

5441

Ischaemic Stroke, excluding all haemorrhages

963

4654

1.54

32.79

4.7

4.1

8.42

8.47

kpa

0.41

940

4541

Other/unspecified dorsalgia

599

3517

1.70

32.29

4.4

3.9

8.68

8.65

kpa

0.17

584

3427

Diabetic maculopathy

304

1380

2.15

32.28

7.0

4.4

8.62

8.68

kpa

0.28

292

1338

Ventral hernia

433

2350

1.87

32.26

4.8

4.0

8.62

8.58

kpa

0.24

423

2302

Other infectious diseases, including avohilmo

194

775

2.58

31.97

6.5

4.5

8.17

8.47

kpa

1.82

187

760

Injuries to the hip and thigh

844

4900

1.56

31.61

4.4

4.0

8.36

8.57

kpa

2.74

828

4776

Injuries to the knee and lower leg

1828

7275

1.37

31.51

4.2

3.9

8.64

8.73

kpa

1.39

1792

7095

Congenital malformations, deformations and chromosomal abnormalities

844

5189

1.55

31.50

5.0

3.6

8.94

8.86

kpa

0.61

825

5072

Other dorsopathies, not elsewhere classified

1504

5564

1.41

31.40

3.9

8.84

8.72

kpa

1.42

1474

5425

Necrosis of pulp, including avohilmo

872

5642

1.54

31.38

3.6

3.9

8.78

8.80

kpa

0.14

848

5525

Fibromyalgia

146

509

2.93

31.21

3.2

3.3

8.94

8.90

kpa

0.08

140

499

KRA_PSY_EATING, excluding more controls

112

331

3.41

31.00

4.2

2.3

9.42

9.37

kpa

0.10

107

326

Systemic connective tissue disorders

567

3367

1.71

30.89

4.7

3.8

8.47

8.59

kpa

1.00

558

3284

Cholecystectomy

1090

6343

1.47

30.74

3.9

4.0

8.71

8.56

kpa

2.04

1066

6185

Suppurative and necrotic conditions of lower respiratory tract

140

488

2.99

30.29

8.6

4.9

8.30

8.42

kpa

0.30

134

479

Pleural plaque with presence of asbestos

175

686

2.65

30.21

4.5

5.2

8.17

8.27

kpa

0.42

170

667

Injuries to the shoulder and upper arm

1348

7423

1.41

29.93

3.9

4.0

8.60

8.67

kpa

0.74

1319

7246

Amputation

212

910

2.39

29.85

9.9

4.8

8.21

8.35

kpa

0.47

207

891

Postviral fatigue syndrome

10.36

29.31

1.5

2.0

9.85

9.92

kpa

0.06

Conductive and sensorineural hearing loss

1240

5790

1.43

29.27

4.0

4.1

8.54

8.56

kpa

0.13

1210

5654

Assault

226

1004

2.30

29.24

4.7

3.8

9.03

9.01

kpa

0.08

216

984

Statin medication

950

3551

1.52

29.11

4.6

3.3

8.76

8.80

kpa

0.26

924

3459

Schizophrenia

267

1278

2.13

28.68

5.2

4.0

8.36

8.86

kpa

6.26

260

1257

Leisure time condition

318

1629

1.99

28.33

4.9

4.3

8.43

8.69

kpa

1.88

308

1600

Diabetic retinopathy

713

2798

1.61

28.20

5.7

4.6

8.47

8.57

kpa

0.87

691

2730

Other bacterial intestinal infections, including avohilmo

389

2132

1.85

28.11

7.2

3.7

8.62

8.61

kpa

0.05

378

2090

Other hearing loss

507

2902

1.72

28.08

4.3

8.43

8.41

kpa

0.13

499

2824

Peripheral artery operations in Hilmo

247

1159

2.18

27.99

9.1

4.4

8.19

8.42

kpa

1.18

241

1132

Diseases of pulp and periapical tissues and dental caries

1006

3485

1.49

27.88

4.3

4.1

8.56

8.53

kpa

0.23

984

3395

Bacterial intestinal infections, IBD co-morbidities

331

1729

1.95

27.86

7.8

4.2

8.56

8.55

kpa

0.03

320

1693

Other diseases of intestine

273

1337

2.08

27.62

5.8

3.8

8.88

8.58

kpa

1.36

265

1307

Mouth breathing

611

3807

1.62

27.43

4.3

4.2

8.84

8.68

kpa

1.71

599

3730

Reimbursement for rheumatic diseases

849

5658

1.50

27.43

4.4

3.8

8.49

8.68

kpa

2.69

832

5523

Adverse effects, not elsewhere classified

307

1572

1.98

27.34

4.2

4.1

8.88

8.80

kpa

0.30

302

1545

Intentional self-harm by sharp object

134

4.84

27.14

4.2

2.2

9.17

9.44

kpa

0.56

134

Superficial injury of hip and thigh

285

1428

2.03

27.07

4.3

8.36

8.50

kpa

0.70

279

1395

Missing teeth due to accident, extraction or parodontitis

980

6038

1.46

27.03

4.7

4.0

8.51

8.58

kpa

0.74

952

5905

Abnormal findings on examination of blood, without diagnosis

800

4803

1.52

26.97

5.5

4.2

8.46

8.53

kpa

0.62

782

4693

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

509

3049

1.69

26.90

4.2

3.9

8.66

8.69

kpa

0.15

498

2988

Other symptoms and signs involving the digestive system and abdomen

242

1145

2.15

26.74

4.7

3.9

8.77

8.55

kpa

1.10

236

1125

Tubulo-interstitial nephritis, not specified as acute or chronic

120

411

3.00

26.63

6.4

3.4

8.72

8.60

kpa

0.27

114

405

Diverticular disease of intestine

1072

4645

1.45

26.55

4.5

3.9

8.53

8.51

kpa

0.14

1045

4527

Dermatitis and eczema

1696

7535

1.34

26.35

4.6

3.8

8.67

8.69

kpa

0.16

1672

7341

Injuries to the ankle and foot

1047

6267

1.44

26.25

4.1

3.8

8.79

8.81

kpa

0.12

1022

6131

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

909

5669

1.47

26.09

4.8

3.6

8.95

8.82

kpa

1.33

889

5542

Caries of dentine, including avohilmo

1183

4272

1.42

25.97

4.2

4.1

8.61

8.58

kpa

0.15

1161

4164

Hernia

1387

6744

1.37

25.96

4.2

3.9

8.68

8.66

kpa

0.15

1349

6580

Superficial injury of abdomen, lower back and pelvis

271

1356

2.03

25.86

4.0

4.2

8.64

8.73

kpa

0.33

265

1332

Acute and transient psychotic disorders

200

896

2.28

25.49

4.7

4.1

8.74

8.79

kpa

0.15

193

879

Open wound of lower leg

268

1345

2.03

25.39

5.4

4.3

8.39

8.72

kpa

2.48

261

1313

Superficial injury of lower leg

407

2333

1.77

25.31

4.3

3.9

8.59

8.75

kpa

1.23

396

2278

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1362

7800

1.37

25.29

4.2

3.9

8.77

8.70

kpa

0.70

1349

7600

Pyothorax

110

372

3.09

25.24

9.0

5.0

8.30

8.44

kpa

0.32

105

365

Bacterial pneumonia (organism specified)

720

4290

1.53

25.23

6.8

3.6

8.30

8.59

kpa

5.08

695

4186

Inflammatory bowel disease

474

2841

1.69

25.04

4.0

3.9

8.84

8.79

kpa

0.20

459

2777

Other disorders of ear

1372

6516

1.37

24.90

4.2

4.1

8.63

kpa

0.02

1340

6364

Presence of other devices

2175

0.29

24.88

3.4

4.1

8.32

8.42

kpa

0.15

2104

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

374

2076

1.80

24.84

5.1

3.6

9.17

8.95

kpa

1.54

367

2041

Personal history of certain other diseases

5.97

24.84

4.9

2.1

8.65

9.46

kpa

1.92

Cerebral cysts

122

440

2.86

24.77

4.7

4.2

9.28

8.60

kpa

4.18

116

434

Fracture of shoulder and upper arm

585

3699

1.60

24.76

4.2

4.0

8.44

8.68

kpa

2.99

570

3612

Other systemic involvement of connective tissue (FG)

389

2173

1.78

24.74

4.3

3.9

8.41

8.59

kpa

1.25

382

2109

Nerve, nerve root and plexus disorders

1602

7238

1.34

24.60

4.0

3.9

8.67

8.65

kpa

0.18

1569

7056

Caries of enamel

754

7295

0.67

24.57

3.6

3.9

8.88

8.75

kpa

1.31

740

7137

Diseases of the ear and mastoid process

1673

6321

1.33

24.44

4.1

3.9

8.75

8.70

kpa

0.48

1632

6172

Left ventricular outflow tract obstruction (LVOTO), broad definition

179

780

2.35

24.43

5.9

4.8

8.68

8.79

kpa

0.29

174

765

DVT of lower extremities

314

1685

1.89

24.40

5.2

4.2

8.64

8.53

kpa

0.51

308

1643

Other diseases of anus and rectum

494

3002

1.66

24.39

4.2

3.7

8.61

8.56

kpa

0.27

478

2925

Bacterial pneumonia, not elsewhere classified

525

2844

1.64

24.20

6.6

2.9

8.29

8.75

kpa

8.86

505

2778

Dental caries, including avohilmo

1105

4003

1.42

24.11

4.3

4.1

8.57

8.55

kpa

0.16

1084

3898

Aortic valve malfunction, age under 60 years

170

731

2.38

23.96

6.0

4.7

8.61

8.78

kpa

0.51

165

716

Rheumatism, unspecified

201

928

2.20

23.77

3.4

3.7

8.93

8.58

kpa

1.54

196

907

Superficial injury of thorax

262

1340

1.99

23.57

4.5

4.4

8.54

8.62

kpa

0.33

254

1309

Arthropathies

1290

4755

1.38

23.45

4.5

3.7

8.73

8.80

kpa

0.64

1270

4632

Abdominal aortic aneurysm (AAA)

204

947

2.19

23.39

5.4

4.7

8.17

8.22

kpa

0.15

195

924

Molar incisor enamel hypoplasia, with caries

10.36

23.31

17.3

9.9

10.94

8.46

kpa

3.38

Irritable bowel syndrome

387

2239

1.75

23.31

3.4

3.5

8.94

8.72

kpa

1.90

377

2192

Polyarthrosis

330

1634

1.84

23.29

3.8

4.1

8.70

8.49

kpa

0.85

323

1589

Panic disorder

203

951

2.16

23.08

3.7

3.6

8.99

8.93

kpa

0.19

195

937

Fitting and adjustment of other devices

154

3024

0.44

22.93

6.3

3.3

8.56

8.46

kpa

0.33

149

2935

Vascular disorders of the intestines

141

570

2.54

22.80

6.1

4.4

8.22

8.37

kpa

0.30

133

555

Obesity, other/unspecified

454

2759

1.66

22.75

4.8

3.4

8.76

8.81

kpa

0.23

442

2708

Nonalcoholic fatty liver disease

173

769

2.30

22.55

4.3

8.97

8.66

kpa

1.43

168

754

Sulfasalazine

377

2186

1.74

22.54

4.2

3.4

8.60

8.79

kpa

1.22

371

2128

Migraine with aura

287

1534

1.89

22.42

2.9

3.5

9.14

8.91

kpa

1.33

281

1507

Organic, including symptomatic, mental disorders

851

4144

1.46

22.40

4.4

4.3

8.32

8.47

kpa

1.57

820

4054

Dental operations

918

3276

1.45

22.37

4.4

4.0

8.51

8.48

kpa

0.16

900

3186

Left bundle-branch block

120

453

2.71

22.26

3.1

3.5

8.63

8.57

kpa

0.14

115

442

Other degenerative diseases of the nervous system

399

1695

1.73

22.22

4.0

8.27

8.52

kpa

2.34

382

1658

Superficial injury of head

381

2234

1.72

21.85

3.9

4.1

8.71

8.63

kpa

0.40

376

2182

Fracture of lower leg, including ankle

809

5523

1.45

21.77

4.5

3.9

8.55

8.71

kpa

1.98

792

5390

Fracture of lumbar spine and pelvis

389

2296

1.71

21.74

4.5

4.2

8.24

8.47

kpa

1.85

371

2241

Disorders of ocular muscles, binocular movement, accommodation and refraction

680

4536

1.50

21.72

4.7

3.8

8.78

8.82

kpa

0.18

665

4435

Periapical abscess

677

4556

1.50

21.72

3.9

4.0

8.75

8.72

kpa

0.18

662

4459

Disorders of refraction and accommodation

407

2427

1.69

21.65

4.7

3.9

8.79

8.82

kpa

0.12

397

2383

Candidiasis, including avohilmo

444

2720

1.65

21.63

5.5

3.7

8.70

kpa

0.01

433

2666

Other necrotizing vasculopathies (FG)

119

457

2.68

21.46

5.9

3.9

8.55

8.47

kpa

0.19

119

446

Lung transplant status

7.35

21.35

12.5

4.4

8.82

8.76

kpa

0.05

Lung transplantation

7.34

21.34

12.5

4.4

8.82

8.76

kpa

0.05

Crohn disease

205

996

2.09

21.32

3.5

4.1

8.98

8.79

kpa

0.76

198

981

388

2148

1.71

21.29

4.5

4.2

8.30

kpa

0.01

377

2083

Ulcerative colitis, NAS

222

1113

2.03

21.19

4.3

4.2

8.84

8.74

kpa

0.33

214

1095

Primary adrenocortical insufficiency

6.47

21.12

4.6

2.5

8.42

8.91

kpa

0.82

Maternal care for other conditions predominantly related to pregnancy

237

1182

1.98

21.11

2.4

2.8

9.41

9.07

kpa

1.83

230

1163

Bronchiectasis

145

616

2.42

21.09

6.1

3.8

8.36

8.51

kpa

0.52

140

599

Examination and observation for other reasons

479

4259

0.63

21.09

4.7

3.7

8.73

8.65

kpa

0.41

468

4165

Colorectal cancer, including Hilmo

405

2273

1.68

20.92

4.4

4.3

8.89

8.36

kpa

4.57

397

2209

Gastric ulcer

312

1762

1.80

20.64

5.4

4.1

8.41

8.47

kpa

0.20

305

1712

Other joint disorders

1230

4747

1.36

20.63

3.9

3.7

8.76

8.80

kpa

0.25

1205

4624

Gonarthrosis [arthrosis of knee](FG)

1069

4468

1.38

20.59

3.9

3.8

8.50

8.59

kpa

0.95

1052

4340

Other gastritis (incl. Duodenitis)

360

2118

1.72

20.58

5.1

4.0

8.49

8.58

kpa

0.41

352

2063

Presence of cardiac and vascular implants and grafts

644

3161

1.51

20.56

5.0

4.1

8.34

8.40

kpa

0.40

634

3072

Ulcerative colitis

360

2124

1.72

20.32

4.1

3.9

8.83

8.76

kpa

0.33

349

2081

Hypoplasia of dental enamel

8.13

20.11

17.8

9.6

11.14

8.69

kpa

5.32

Other and unspecified tonsillitis

425

2163

1.65

20.10

3.9

3.5

9.16

8.99

kpa

1.12

418

2119

Other viral diseases, not elsewhere classified

276

1508

1.85

20.10

6.5

4.2

8.92

8.79

kpa

0.60

269

1484

Phobic anxiety disorders

176

823

2.16

20.04

3.1

3.5

8.90

9.10

kpa

0.80

170

811

Combinations of oral blood glucose lowering drugs

420

2591

1.64

19.99

4.4

3.9

8.46

8.54

kpa

0.44

411

2548

Fracture of foot, except ankle

363

2161

1.70

19.83

4.5

4.0

8.74

8.80

kpa

0.34

353

2118

severe traumatic brain injury, does not include concussion

389

2363

1.67

19.74

4.3

8.20

8.50

kpa

3.28

377

2298

Colorectal cancer

369

2121

1.69

19.57

4.3

8.91

8.34

kpa

4.57

362

2058

Complications of internal orthopaedic prosthetic devices, implants and grafts

362

2164

1.70

19.54

4.3

3.9

8.36

8.44

kpa

0.35

357

2106

Testicular hypofunction

258

3.18

19.30

3.9

4.4

9.09

8.70

kpa

0.91

252

Polyneuropathies and other disorders of the peripheral nervous system

361

2173

1.69

19.03

6.3

4.1

8.60

8.54

kpa

0.30

351

2125

Cholecystitis

232

1228

1.92

18.96

4.8

4.3

8.60

8.38

kpa

1.20

227

1199

Fracture of femur

465

2675

1.58

18.93

4.8

4.2

8.24

8.41

kpa

1.22

455

2593

5-aminosalicylic acid

278

1557

1.81

18.86

4.1

3.4

8.82

8.89

kpa

0.27

270

1525

Striking against or struck by other objects

488

3159

1.56

18.76

3.6

4.2

8.76

8.90

kpa

1.09

476

3096

Injuries to the neck

340

2021

1.70

18.72

3.4

4.1

8.86

8.80

kpa

0.25

334

1982

Coronary artery bypass grafting

379

1697

1.68

18.71

5.8

3.8

8.38

8.46

kpa

0.39

369

1649

Glaucoma

865

5302

1.40

18.61

4.5

4.1

8.56

8.46

kpa

0.91

850

5162

Nonorganic sleeping disorders

310

1803

1.74

18.49

3.9

4.0

9.07

8.85

kpa

1.60

302

1775

Open wound of forearm

171

823

2.12

18.37

5.0

4.3

8.86

8.61

kpa

1.08

162

811

Other necrotizing vasculopathies

138

611

2.32

18.35

5.7

4.9

8.55

8.48

kpa

0.17

138

603

Testicular dysfunction

300

2.93

18.13

3.8

4.3

9.08

8.67

kpa

1.05

293

Vitamin deficiency, wide

334

2.80

17.99

5.8

3.8

8.70

8.60

kpa

0.22

328

Vitamin deficiency

334

2.80

17.99

5.8

3.8

8.70

8.60

kpa

0.22

328

Sulfonylureas

534

2814

1.52

17.93

5.5

4.1

8.11

8.35

kpa

2.82

510

2744

Gonarthrosis

914

3743

1.39

17.88

4.0

3.9

8.51

8.59

kpa

0.76

900

3638

Use of disulfiram, acamprosate or naltrexone

149

688

2.21

17.84

4.7

4.2

8.68

8.83

kpa

0.59

143

674

Other and unspecified polyneuropathies, also in other diseases

319

1897

1.71

17.67

6.6

4.2

8.62

8.52

kpa

0.45

309

1859

Degeneration of macula and posterior pole

754

4135

1.42

17.58

4.2

4.1

8.37

8.41

kpa

0.32

733

4034

501

2837

1.53

17.58

4.4

4.1

8.29

8.33

kpa

0.22

486

2756

Assault by other specified means

6.39

17.56

4.6

2.3

8.88

9.23

kpa

0.41

Other obstetric conditions, not elsewhere classified

326

1208

1.72

17.23

2.4

2.6

9.57

9.22

kpa

2.56

319

1188

Zoster [herpes zoster], including avohilmo

761

5282

1.40

17.06

4.2

3.9

8.61

8.56

kpa

0.34

749

5148

Alzheimer’s disease (Atypical or mixed), excluding more controls

163

580

2.14

17.02

3.9

4.3

7.86

8.18

kpa

2.12

154

565

Use of pramipexole

336

2047

1.66

16.95

4.8

4.2

8.47

8.50

kpa

0.10

326

2012

Focal brain injury

104

420

2.53

16.92

4.0

4.4

7.92

8.49

kpa

3.58

411

Fitting and adjustment of external prosthetic device

15.39

16.91

13.3

1.7

8.51

8.35

kpa

0.19

Crohn's disease NAS

108

445

2.48

16.88

3.8

4.0

9.03

8.79

kpa

0.88

103

438

Urticaria and erythema

486

3224

1.52

16.84

4.5

3.8

8.86

8.77

kpa

0.54

476

3151

Paracetamol or NSAID medication

222

578

1.95

16.83

4.5

4.3

8.79

8.82

kpa

0.06

217

561

Rheumatoid arthritis

449

2587

1.55

16.74

4.4

3.9

8.42

8.59

kpa

1.32

440

2519

Herpesviral [herpes simplex] infections

178

908

1.99

16.32

5.2

4.1

9.03

8.66

kpa

1.46

178

895

Other viral diseases, not elsewhere classified, including avohilmo

359

2228

1.62

16.30

5.6

3.9

9.08

8.84

kpa

1.77

351

2183

Candidiasis

214

1164

1.87

16.14

7.5

3.9

8.68

kpa

0.00

208

1144

Malignant neoplasm of bladder, including Hilmo

198

1037

1.92

16.13

4.2

4.5

8.38

8.28

kpa

0.38

193

1005

Other systemic involvement of connective tissue

394

2532

1.57

15.91

4.3

4.0

8.41

8.55

kpa

0.94

386

2474

Arthrosis

980

4013

1.34

15.77

3.8

8.51

8.64

kpa

1.53

963

3905

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

314

1179

1.69

15.76

2.4

2.6

9.59

9.24

kpa

2.38

307

1159

Artificial joint operation, meniscal resection

1315

6576

1.28

15.64

3.6

4.2

8.53

8.57

kpa

0.43

1294

6405

Spondyloarthritis

259

1504

1.74

15.64

4.9

4.2

8.55

8.68

kpa

0.55

251

1470

Primary open-angle glaucoma, strict

420

2750

1.54

15.45

4.7

4.1

8.59

8.39

kpa

1.46

410

2674

Other symptoms and signs involving cognitive functions and awareness

718

4611

1.39

15.32

4.5

4.1

8.46

8.51

kpa

0.42

696

4509

Polycystic ovarian syndrome, consortium definition

851

3596

1.36

15.18

3.5

3.3

8.81

8.80

kpa

0.02

834

3507

Other blood glucose lowering drugs, excl. Insulins

238

1369

1.76

14.95

5.9

3.9

8.31

8.48

kpa

0.87

230

1341

Colorectal adenocarcinoma

305

1851

1.65

14.86

4.5

4.3

8.92

8.33

kpa

4.32

300

1797

Deforming dorsopathies

382

2475

1.56

14.85

3.6

4.0

8.60

8.68

kpa

0.41

370

2415

Renal tubulo-interstitial disorders in diseases classified elsewhere

5.45

14.85

9.5

2.5

8.98

8.29

kpa

1.39

Colectomy operation

266

1582

1.71

14.83

5.2

4.3

9.02

8.47

kpa

3.41

259

1546

IBD patients in KELA-register

305

1883

1.64

14.62

3.3

3.8

9.00

8.81

kpa

1.07

295

1845

Spinal stenosis

739

3981

1.38

14.55

3.9

4.1

8.44

8.47

kpa

0.21

722

3879

Eating disorder

113

506

2.26

14.53

4.2

2.8

9.44

9.34

kpa

0.19

108

501

Late syphilis

4.27

14.52

9.8

3.5

8.28

8.52

kpa

0.39

Thyrotoxicosis, other and/or unspecified

267

1597

1.69

14.50

3.6

3.7

8.58

8.62

kpa

0.13

262

1567

Acute suppurative otitis media

329

1932

1.60

14.31

4.5

3.6

9.12

9.11

kpa

0.03

322

1891

Varicose veins

844

4777

1.34

14.17

4.4

4.0

8.36

8.53

kpa

2.15

827

4650

Umbilical hernia

404

2689

1.52

13.97

4.7

4.2

8.79

8.67

kpa

0.55

391

2638

Malignant neoplasm of skin, including Hilmo

689

3351

1.39

13.92

4.1

8.56

8.46

kpa

0.83

681

3262

Behavioural syndromes associated with physiological disturbances and physical factors

1296

6953

1.27

13.91

3.7

4.0

8.88

8.71

kpa

3.00

1268

6790

Coxibs

444

1545

1.52

13.89

3.8

4.9

8.66

8.61

kpa

0.25

437

1502

Tracheo-bronchomalasia

20.06

13.69

2.9

4.0

8.67

10.23

kpa

0.72

Fracture of skull and facial bones

296

1850

1.62

13.55

3.5

4.1

8.59

8.76

kpa

1.00

290

1815

Other disorders of veins

541

3768

1.42

13.50

4.7

3.8

8.44

8.65

kpa

2.26

533

3675

Injuries to the elbow and forearm

987

6541

1.30

13.47

4.3

3.9

8.73

kpa

0.03

956

6398

Malignant neoplasm of breast

450

1959

1.49

13.47

3.6

3.4

8.50

8.63

kpa

0.79

436

1907

Adenocarcinoma and ductal carcinoma of pancreas

251

2.79

13.44

4.7

4.4

9.65

8.36

kpa

3.34

245

Disorders of sclera, cornea, iris and ciliary body

757

5665

1.34

13.41

4.3

3.9

8.71

8.70

kpa

0.09

736

5544

Malignant neoplasm of skin

655

3214

1.39

13.41

3.8

4.1

8.54

8.44

kpa

0.78

646

3126

Malignant neoplasm of breast, HER2-negative

449

1959

1.49

13.32

3.6

3.4

8.49

8.63

kpa

0.84

435

1907

Persistent mood disorders

254

1536

1.67

13.28

5.4

3.7

8.52

8.65

kpa

0.64

245

1505

Visual disturbances

686

5069

1.36

13.25

4.1

3.9

8.77

8.64

kpa

1.22

674

4941

Other disorders of lacrimal gland

503

3533

1.43

13.18

4.0

3.9

8.78

8.64

kpa

1.14

493

3448

Mycoses

401

2703

1.50

13.06

6.7

3.9

8.58

8.68

kpa

0.46

389

2644

Benign neoplasm of other and unspecified endocrine glands

196

1111

1.79

13.04

3.5

4.5

8.70

8.55

kpa

0.45

191

1095

Mucosal proctocolitis

179

989

1.83

12.95

3.4

4.0

8.91

8.79

kpa

0.39

174

972

Toxic effects of substances chiefly nonmedicinal as to source

171

934

1.86

12.87

4.1

4.3

9.13

8.74

kpa

1.66

160

919

Abnormal involuntary movements

196

1116

1.78

12.84

4.2

4.4

9.03

8.56

kpa

3.63

196

1096

Urethral stricture

104

478

2.23

12.78

4.2

5.3

8.84

8.47

kpa

1.19

470

Other disorders of nervous system

113

539

2.14

12.63

4.6

5.1

8.59

8.43

kpa

0.29

108

532

Malignant neoplasm of breast, including Hilmo

451

1978

1.47

12.60

3.6

3.4

8.48

8.63

kpa

1.20

436

1925

Malignant neoplasm of breast, HER2-negative, including Hilmo

451

1979

1.47

12.58

3.6

3.4

8.48

8.63

kpa

1.21

436

1926

Primary open-angle glaucoma

486

3293

1.43

12.53

4.5

4.2

8.60

8.39

kpa

1.64

475

3201

Sleep disorders

1231

6771

1.26

12.52

3.4

3.9

8.88

8.72

kpa

2.48

1208

6610

Sequelae of injuries, of poisoning and of other consequences of external causes

321

2085

1.55

12.49

3.9

4.0

8.54

8.75

kpa

1.53

313

2046

Eating disorders

132

669

2.00

12.36

4.4

3.3

9.34

9.14

kpa

0.50

127

661

Other abnormal uterine and vaginal bleeding

290

1311

1.60

12.27

4.0

3.5

8.49

8.65

kpa

0.77

284

1277

Sarcoidosis

191

1096

1.77

12.22

3.4

4.4

8.44

8.55

kpa

0.41

191

1080

Urticaria

378

2552

1.49

12.21

3.9

3.8

9.00

8.77

kpa

1.79

369

2499

Congenital malformations of the circulatory system

198

1113

1.75

12.19

5.5

4.6

8.60

8.81

kpa

0.84

191

1095

Other malignant neoplasms of skin (=non-melanoma skin cancer)

598

2949

1.38

12.16

4.0

4.1

8.50

8.42

kpa

0.56

588

2868

Inflammatory bowel disease, strict (require KELA)

305

1972

1.56

12.13

3.3

3.9

9.00

8.84

kpa

0.82

295

1936

Unspecified misadventure during surgical and medical care

450

2.23

12.10

7.6

4.8

8.52

8.49

kpa

0.05

444

Benign paroxysmal vertigo

420

2904

1.46

12.07

3.9

8.66

8.54

kpa

0.74

409

2838

Abnormal reflex

6.08

11.94

6.6

2.6

9.06

8.48

kpa

0.92

Syndrome of inappropriate secretion of antidiuretic hormone

6.21

11.74

3.6

2.6

8.99

8.03

kpa

1.85

Osteonecrosis

104

495

2.15

11.73

6.3

4.6

8.62

8.51

kpa

0.21

104

486

Symptoms and signs involving speech and voice

457

3227

1.43

11.71

3.8

3.9

8.66

8.57

kpa

0.40

446

3154

Other fall from one level to another

315

2067

1.54

11.71

4.0

4.3

8.77

8.80

kpa

0.12

305

2025

Coxarthrosis [arthrosis of hip](FG)

745

3884

1.33

11.56

4.0

3.9

8.45

8.52

kpa

0.47

727

3777

Inflammatory diseases of female pelvic organs

718

3703

1.33

11.52

3.8

3.2

8.91

8.79

kpa

0.93

701

3618

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

614

3050

1.37

11.52

4.1

8.47

8.42

kpa

0.27

605

2964

Chronic periodontitis, complicated

782

5859

1.31

11.48

4.7

4.0

8.57

8.61

kpa

0.23

766

5732

Suppurative and unspecified otitis media

445

2769

1.43

11.48

4.4

3.7

9.12

8.97

kpa

0.96

438

2711

Visual disturbances and blindness

729

5555

1.32

11.40

4.1

4.0

8.75

8.63

kpa

1.08

715

5416

Benign neoplasms

1372

6077

1.23

11.37

4.3

3.8

8.77

8.73

kpa

0.31

1340

5933

Chronic sinusitis

564

4142

1.37

11.31

3.8

4.0

8.78

8.68

kpa

0.78

551

4035

Somatoform disorder

208

1249

1.68

11.27

5.3

3.9

8.82

8.72

kpa

0.40

202

1229

Malignant neoplasm of colon, including Hilmo

262

1659

1.59

11.26

4.1

4.2

8.88

8.36

kpa

3.00

255

1608

malignant neoplasm of male genital organs, including Hilmo

427

1776

1.46

11.26

3.9

4.7

8.45

8.40

kpa

0.17

418

1728

Myocardial infarction, unclassifiable

356

2157

1.49

11.18

5.9

4.4

8.25

8.31

kpa

0.30

343

2090

Irregular menses

514

2782

1.39

11.18

3.4

3.2

8.99

8.90

kpa

0.50

505

2722

Infections with a predominantly sexual mode of transmission, including avohilmo

459

2983

1.42

11.18

4.1

3.6

8.96

9.04

kpa

0.50

448

2927

Congenital malformations of heart and great arteries

174

968

1.77

11.13

5.0

4.6

8.42

8.86

kpa

2.50

169

951

Pre-eclampsia or poor fetal growth

301

1969

1.53

11.11

3.3

3.0

9.13

8.98

kpa

0.67

291

1935

Seropositive rheumatoid arthritis

323

2145

1.51

11.09

4.8

4.0

8.41

8.59

kpa

1.07

317

2083

Disorders of eyelid, lacrimal system and orbit

1204

7144

1.24

11.01

3.9

4.0

8.66

8.62

kpa

0.31

1175

6973

Diseases of oral cavity, salivary glands and jaws

831

3296

1.31

10.95

4.4

4.0

8.47

8.50

kpa

0.21

815

3206

Abnormality of white blood cells, not elsewhere classified

4.83

10.90

7.1

3.5

8.26

8.70

kpa

0.44

In situ neoplasms

558

4124

1.36

10.90

4.6

3.9

8.56

8.53

kpa

0.15

547

4022

Metabolic disorder, other/unspecified

16.39

10.89

3.3

1.2

8.85

8.74

kpa

0.05

Disorders of adrenal gland, other and/or unspecified

9.37

10.87

3.1

2.2

9.06

9.15

kpa

0.05

Disorders of lacrimal system

591

4348

1.35

10.62

3.8

3.9

8.72

8.62

kpa

0.80

579

4242

Urolithiasis

471

3404

1.40

10.62

3.9

4.3

8.73

8.54

kpa

1.65

460

3324

Malignant neoplasm of colon

218

1350

1.63

10.52

4.2

8.92

8.38

kpa

2.52

212

1310

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

712

5275

1.31

10.52

3.8

4.1

8.85

8.66

kpa

1.89

702

5148

Necrotizing fasciitis

8.66

10.42

5.7

3.8

9.02

8.13

kpa

1.08

Polyarteritis nodosa and related conditions

3.80

10.40

4.3

3.5

8.55

kpa

0.00

malignant neoplasm of male genital organs

414

1744

1.44

10.39

3.9

4.7

8.48

8.40

kpa

0.38

405

1696

Basal cell carcinoma, including Hilmo

588

2962

1.35

10.38

4.0

4.1

8.50

8.41

kpa

0.59

581

2878

Malignant neoplasm of breast, HER-positive

348

1766

1.48

10.35

3.5

3.4

8.61

8.57

kpa

0.18

335

1722

Car occupant injured in other and unspecified transport accidents

248

1592

1.57

10.28

3.8

4.0

8.69

8.83

kpa

0.58

242

1562

Transient ischemic attack

743

4576

1.30

10.25

4.3

4.1

8.38

8.48

kpa

0.91

724

4463

Malignant neoplasm of breast, ER-positive, including Hilmo

348

1769

1.47

10.20

3.5

3.4

8.61

8.57

kpa

0.18

335

1725

Diabetes mellitus in pregnancy

296

1237

1.53

10.15

2.7

2.8

9.48

9.14

kpa

2.78

290

1217

Glaucoma suspect

505

3718

1.37

10.12

4.6

4.0

8.61

8.52

kpa

0.60

497

3623

Malignant neoplasm of prostate, including Hilmo

412

1708

1.44

10.09

3.9

4.7

8.42

8.37

kpa

0.20

403

1660

Disorders of phosphorus metabolism and phosphatases

10.42

10.03

4.5

1.5

9.32

8.35

kpa

0.62

Calculus of kidney and ureter

433

3120

1.40

9.98

4.0

4.3

8.72

8.56

kpa

1.21

422

3047

Ovarian cyst

403

1613

1.44

9.97

3.4

8.93

8.78

kpa

0.80

394

1571

Coxarthrosis

682

3362

1.32

9.97

4.0

8.47

8.50

kpa

0.17

666

3270

Vascular diseases of the intestine

323

2.32

9.94

5.4

4.7

8.52

8.27

kpa

0.30

317

Basal cell carcinoma

566

2875

1.35

9.94

3.9

4.1

8.50

8.40

kpa

0.71

558

2797

Sciatica+with lumbago

663

4507

1.31

9.78

3.5

3.9

8.69

8.65

kpa

0.25

650

4399

Excessive earwax

894

6462

1.26

9.74

3.4

4.2

8.68

8.59

kpa

0.80

878

6308

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

459

3324

1.37

9.41

3.7

8.84

8.97

kpa

1.01

451

3257

Disorders of optic nerve and visual pathways

128

709

1.83

9.35

5.2

4.1

8.73

8.69

kpa

0.08

123

699

Malignant neoplasm of prostate

399

1675

1.42

9.32

3.9

4.8

8.46

8.36

kpa

0.51

390

1627

Other maternal disorders predominantly related to pregnancy

567

2666

1.34

9.27

3.1

3.3

8.95

8.83

kpa

0.80

552

2610

Functional dyspepsia

343

2406

1.44

9.24

4.2

3.7

8.84

8.66

kpa

1.15

334

2354

Unknown and unspecified causes of morbidity

378

2.14

9.23

5.7

3.5

8.84

8.66

kpa

0.48

371

Insomnia

1175

6730

1.22

9.18

3.3

3.9

8.88

8.73

kpa

2.15

1153

6566

Hepatomegaly and splenomegaly, not elsewhere classified

4.77

9.17

7.9

4.4

9.33

8.47

kpa

1.05

Gonarthrosis, primary, with knee surgery

817

5049

1.27

9.14

3.7

4.3

8.46

8.47

kpa

0.05

803

4918

Diseases of male genital organs

739

2893

1.29

9.13

4.8

4.5

8.86

8.61

kpa

3.06

722

2822

Myalgia

288

1959

1.48

9.13

3.5

3.8

9.02

8.71

kpa

2.85

282

1913

Appendectomy

809

6126

1.26

9.09

3.7

3.8

8.81

8.77

kpa

0.30

797

5983

4.66

8.94

8.0

1.6

9.49

9.18

kpa

0.27

Iridocyclitis

297

2043

1.47

8.93

4.2

4.1

8.68

kpa

0.01

288

2003

Dementia in Alzheimer disease

304

1750

1.47

8.91

3.8

4.7

7.89

8.24

kpa

3.87

290

1696

Strabismus

330

2312

1.43

8.84

5.4

4.0

8.82

8.75

kpa

0.30

322

2269

Evidence of alcohol involvement determined by level of intoxication

4.29

8.83

4.7

2.5

8.42

9.17

kpa

1.09

Other/unspecified mastoiditis and related conditions

7.02

8.78

3.2

8.77

8.41

kpa

0.42

Disorders of vestibular function (Vertigo)

633

4791

1.29

8.72

3.8

3.9

8.63

8.57

kpa

0.50

617

4677

Fall on same level involving ice and snow

771

6137

1.26

8.70

3.7

4.0

8.63

8.68

kpa

0.33

754

5995

Diseases of middle ear and mastoid

720

4629

1.28

8.70

4.2

3.7

8.97

8.84

kpa

1.21

701

4525

Diseases of appendix

956

6958

1.23

8.67

3.6

4.0

8.76

8.71

kpa

0.34

940

6800

Other (seronegative) rheumatoid arthritis, wide

249

1665

1.51

8.66

4.0

4.2

8.46

8.53

kpa

0.23

244

1633

Appendicitis, broad definition

948

6926

1.23

8.59

3.6

4.0

8.76

8.72

kpa

0.34

933

6768

Inflammatory diseases of the central nervous system

119

664

1.82

8.54

6.8

4.4

8.50

8.60

kpa

0.26

111

653

ILD and respiratory illness in diseases classified elsewhere

5.25

8.54

11.9

2.9

7.93

8.49

kpa

0.65

Primary gonarthrosis, bilateral

717

4742

1.27

8.51

3.6

4.2

8.54

8.47

kpa

0.46

706

4619

Thyrotoxicosis

313

2195

1.44

8.50

3.4

3.8

8.60

kpa

0.00

307

2151

Progressive vascular leukoencephalopathy

362

0.16

8.43

1.8

4.8

9.28

8.19

kpa

—

354

Polyglandular dysfunction

11.74

8.41

10.3

1.4

8.97

9.50

kpa

0.31

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

468

1.96

8.30

4.7

3.7

9.15

9.08

kpa

0.14

461

Right bundle-branch block

221

2.45

8.29

5.3

3.9

8.16

8.49

kpa

0.71

214

Other factor of the environment

3.70

8.23

5.6

2.5

8.77

8.99

kpa

0.29

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

224

1487

1.52

8.09

3.3

4.1

8.91

8.81

kpa

0.38

218

1463

Erectile dysfunction, exclusion

9.36

8.07

6.7

2.8

6.48

8.11

kpa

1.70

Exposure to other specified factors

1062

7557

1.21

8.04

4.1

3.9

8.78

8.74

kpa

0.33

1040

7384

Gonarthrosis,primary

1219

6145

1.20

8.03

3.8

4.2

8.52

8.53

kpa

0.11

1201

5984

Ulcerative colitis (strict definition, require KELA)

211

1387

1.54

7.99

3.2

4.2

8.89

8.82

kpa

0.27

205

1365

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

205

1342

1.54

7.92

3.2

4.1

8.88

8.83

kpa

0.17

199

1321

Other ulcerative colitis

416

2.00

7.92

4.4

4.1

9.04

8.84

kpa

0.37

408

Excessive, frequent and irregular menstruation

427

1680

1.36

7.82

3.2

3.4

8.95

8.82

kpa

0.73

421

1637

Rheumatoid arthritis, including avohilmo

482

3672

1.32

7.82

4.3

3.9

8.44

8.58

kpa

0.97

471

3586

Acetic acid derivatives and related substances

403

1520

1.38

7.82

4.8

4.9

8.57

8.59

kpa

0.10

394

1477

Medical observation and evaluation for suspected diseases and conditions

667

4304

0.79

7.81

4.3

3.7

8.88

8.64

kpa

2.56

656

4206

Pre-eclampsia

195

1266

1.55

7.80

3.3

2.9

9.01

8.87

kpa

0.46

189

1246

Disorders of skin appendages

613

4802

1.28

7.67

4.2

3.7

8.88

8.83

kpa

0.32

602

4690

Infections with a predominantly sexual mode of transmission

328

2359

1.39

7.63

4.9

3.5

8.80

8.99

kpa

1.29

320

2314

Alzheimer disease, excluding more controls

228

982

1.51

7.60

3.9

4.0

7.94

8.39

kpa

4.78

216

960

Pure hypercholesterolaemia

902

4681

1.23

7.59

4.5

3.6

8.42

8.60

kpa

2.80

882

4570

Redundant prepuce, phimosis and paraphimosis

292

2037

1.42

7.52

4.8

4.4

8.85

8.70

kpa

0.81

282

1982

Keratitis

459

3497

1.32

7.47

4.5

3.9

8.76

8.70

kpa

0.32

448

3421

Polyuria

305

2183

1.41

7.47

3.5

4.1

8.46

8.53

kpa

0.35

292

2136

Scabies, including avohilmo

177

1138

1.57

7.43

5.4

4.1

8.74

9.01

kpa

1.29

172

1119

Preterm labour and delivery

249

1720

1.46

7.38

3.2

3.3

8.96

8.81

kpa

0.60

242

1686

Fall on and from stairs and steps

343

2508

1.38

7.37

4.6

4.0

8.57

8.67

kpa

0.52

330

2453

Open wound of wrist and hand

588

4481

1.27

7.27

3.7

4.1

8.89

8.77

kpa

0.95

566

4391

Acute and subacute iridocyclitis

243

1680

1.46

7.23

4.4

4.1

8.69

kpa

0.03

236

1653

Wet age-related macular degeneration

263

1778

1.44

7.22

4.1

4.3

8.24

8.26

kpa

0.08

255

1720

Follicular lymphoma, hilmo

335

2.08

7.20

2.8

4.9

8.92

8.47

kpa

0.83

330

Non-small cell lung cancer, squamous

377

2.00

7.11

5.5

5.3

8.05

8.11

kpa

0.11

363

Myeloproliferative diseases

121

718

1.71

7.11

4.5

4.9

8.24

8.43

kpa

0.54

121

707

Defects in the complement system

4.59

7.07

3.4

2.6

9.56

9.21

kpa

0.30

Parkinson's disease, excluding more controls

163

956

1.58

7.04

3.9

4.1

8.27

8.45

kpa

0.72

158

937

Acute appendicitis

870

6669

1.21

6.98

3.6

3.9

8.78

8.73

kpa

0.37

856

6516

Gingivitis and periodontal diseases

1362

6002

1.18

6.96

3.9

4.0

8.71

8.63

kpa

0.87

1338

5853

Autoimmune polyglandular failure

15.06

6.95

10.5

1.4

9.27

9.62

kpa

—

Degenerative macular diseases

171

1112

1.56

6.91

4.5

8.46

8.32

kpa

0.43

164

1092

Spirochaetal infections, other/unspecified

773

0.38

6.86

5.2

4.5

8.81

8.54

kpa

0.51

762

Intracerebral haemorrhage

187

1242

1.52

6.84

4.7

4.6

8.30

8.31

kpa

0.05

178

1214

Pain in joint

674

3318

1.25

6.83

4.1

3.8

8.90

8.66

kpa

2.56

658

3244

Oesophagitis

432

1.91

6.83

6.2

4.5

8.83

8.46

kpa

1.05

426

Pruritus

147

926

1.60

6.81

5.5

4.1

8.66

8.70

kpa

0.11

140

909

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

319

2342

1.37

6.74

4.9

4.0

8.42

8.53

kpa

0.56

313

2292

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

182

1193

1.52

6.73

5.3

4.3

8.28

8.25

kpa

0.09

177

1154

Myocardial infarction, with ST-elevation

256

1814

1.42

6.71

5.9

4.5

8.36

8.40

kpa

0.18

250

1763

Anterior Iridocyclitis

255

1805

1.42

6.71

4.3

4.2

8.68

8.66

kpa

0.06

248

1774

Lesion of radial nerve

259

2.16

6.57

4.9

5.1

8.74

8.45

kpa

0.59

254

Amenorrhoea

332

2.01

6.56

4.2

2.8

8.59

9.17

kpa

2.24

326

Gestational diabetes (for exclusion)

318

1598

1.37

6.52

2.2

2.9

9.44

9.13

kpa

2.46

312

1565

Lifestyle-related condition

3.41

6.50

6.1

2.9

8.80

8.84

kpa

0.05

Pre-eclampsia or eclampsia

204

1399

1.47

6.37

3.2

9.03

8.85

kpa

0.68

198

1375

Use of trihexyphenidyl

14.51

6.32

5.8

3.3

8.23

8.10

kpa

—

Alzheimer’s disease (Atypical or mixed)

178

1177

1.51

6.30

3.7

4.5

7.96

8.21

kpa

1.45

167

1140

Other and unspecified psoriasis

539

1.77

6.29

4.1

4.8

8.73

8.55

kpa

0.33

529

Other strabismus

252

1795

1.41

6.26

5.4

4.1

8.95

8.80

kpa

0.61

246

1768

Myeloproliferative diseases (CML excluded)

108

645

1.70

6.25

4.7

4.9

8.19

8.43

kpa

0.70

108

637

Otitis media, unspecified

134

775

1.61

6.23

5.7

3.9

9.49

9.07

kpa

1.72

134

760

Other/unspecified seropositive rheumatoid arthritis

321

2391

1.35

6.22

4.9

4.0

8.41

8.53

kpa

0.61

315

2341

Pediculosis, acariasis and other infestations, including avohilmo

202

1391

1.46

6.19

5.3

4.1

8.76

8.95

kpa

0.84

196

1371

Alcoholic gastritis

2.92

6.19

7.3

6.4

8.70

8.58

kpa

0.13

Periodontitis

1313

7213

1.16

6.15

4.0

3.9

8.61

8.67

kpa

0.65

1290

7038

Extrapyramidal and movement disorders

517

4119

1.26

6.03

3.8

4.1

8.57

8.52

kpa

0.23

504

4025

Seropositive rheumatoid arthritis, wide

323

2420

1.34

6.03

4.8

4.0

8.41

8.54

kpa

0.69

317

2370

Abnormality of red blood cells

5.35

6.03

3.2

2.8

8.24

8.71

kpa

0.44

Hypertrophic cardiomyopathy

338

1.96

5.98

7.8

5.2

8.13

8.49

kpa

1.01

333

Primary hyperparathyroidism

141

910

1.57

5.96

5.1

3.9

8.52

8.49

kpa

0.08

141

893

Motorcycle rider injured in other and unspecified transport accidents

423

1.85

5.96

4.0

4.4

8.79

9.03

kpa

0.63

415

5.25

5.92

12.5

3.1

7.89

8.50

kpa

0.68

Haemorrhoids and perianal venous thrombosis

435

3382

1.28

5.85

4.2

3.7

8.55

8.54

kpa

0.03

429

3296

Lumbar disc prolapse

779

4791

1.21

5.85

3.6

3.9

8.78

8.66

kpa

1.10

761

4680

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

212

1490

1.43

5.85

4.0

3.6

9.01

9.09

kpa

0.29

205

1465

Underdevelopment of the second kidney

15.34

5.84

13.6

4.9

9.03

9.89

kpa

—

Mental and behavioural disorders due to hallucinogens

5.50

5.84

6.1

2.3

8.72

9.36

kpa

0.65

Abnormal serum enzyme levels

254

3337

0.73

5.78

5.0

4.4

8.57

8.49

kpa

0.33

247

3265

Fissure and fistula of anal and rectal regions

285

2117

1.35

5.66

3.2

3.6

8.71

8.70

kpa

0.03

279

2067

Personal history of allergy to drugs, medicaments and biological substances

3.91

5.58

6.2

2.7

8.66

8.94

kpa

0.28

Chronic periodontitis, including avohilmo

1302

7217

1.15

5.54

4.1

3.9

8.61

8.67

kpa

0.63

1280

7042

Early complications of trauma

340

1.91

5.54

5.7

4.6

8.52

8.67

kpa

0.30

335

!Aliquae complicationes praecoces traumatis

340

1.91

5.54

5.7

4.6

8.52

8.67

kpa

0.30

335

Membranous nephropathy

6.06

5.53

9.3

2.8

8.95

8.48

kpa

0.47

Urethritis and urethral syndrome

117

2.62

5.51

4.8

3.3

9.35

8.76

kpa

0.47

117

Spondylolisthesis/Spondylolysis

213

1518

1.41

5.48

2.7

4.0

8.50

8.60

kpa

0.40

204

1486

Other congenital malformations

576

1.68

5.47

4.5

4.3

9.14

9.00

kpa

0.35

569

Chronic diseases of tonsils and adenoids

686

5215

0.83

5.46

3.8

3.9

9.01

8.77

kpa

2.90

674

5095

Triptan medication for migraine, min. 3 purchases

590

3591

1.23

5.43

2.9

3.6

9.07

8.92

kpa

1.15

575

3516

Benign thyroid growths and nodules

372

2679

1.30

5.42

3.8

3.9

8.67

8.54

kpa

0.51

361

2623

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

5.90

5.40

4.9

4.0

8.61

9.11

kpa

0.33

Hyperplasia of prostate

510

2295

1.26

5.40

4.6

4.8

8.64

8.41

kpa

2.00

498

2240

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

3.54

5.39

3.9

3.6

8.53

8.40

kpa

0.11

Congenital malformations of gallbladder, bile ducts and liver

3.40

5.38

9.7

2.8

9.27

8.69

kpa

0.45

Other specified disorders of muscle

174

2.28

5.37

3.7

4.7

9.01

8.71

kpa

0.41

169

Pain and other conditions associated with female genital organs and menstrual cycle

204

1205

1.42

5.35

2.2

3.2

8.98

8.96

kpa

0.07

196

1176

Nontraumatic intracranial haemmorrhage

275

2053

1.35

5.32

4.8

4.3

8.36

8.40

kpa

0.20

257

2001

Carbimazole or st.post thyroidectomy, condition for graves disease

233

1697

1.38

5.28

3.5

3.8

8.59

8.66

kpa

0.26

227

1666

Allergic urticaria

590

1.66

5.28

3.8

8.85

8.86

kpa

0.01

583

Toxic effect of corrosive substances

5.13

5.24

5.6

4.0

9.03

9.45

kpa

0.33

Carcinoma in situ of skin of trunk

298

1.96

5.23

5.5

4.8

8.54

8.18

kpa

0.83

293

Special screening examination for neoplasms

712

0.44

5.23

3.6

4.2

8.46

8.50

kpa

0.05

700

Other extrapyramidal and movement disorders in other diseases

310

2364

1.32

5.19

3.8

4.1

8.78

8.60

kpa

1.09

302

2318

574

4229

1.23

5.19

4.7

4.2

8.53

8.39

kpa

1.24

566

4119

Synovial cyst of popliteal space [Baker]

586

1.66

5.18

4.2

4.5

8.76

8.54

kpa

0.52

572

Exclusion endpoint for clefts

103

2.67

5.17

6.0

5.0

8.91

9.05

kpa

0.13

103

Thyrotropin deficiency

3.10

5.17

5.4

2.4

8.81

9.01

kpa

0.24

Epidural haemorrhage

3.66

5.10

3.9

5.0

9.11

8.40

kpa

0.74

Dementia, including avohilmo

660

3733

1.21

5.08

3.8

4.4

8.23

8.40

kpa

1.48

635

3648

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

6.59

5.07

13.3

1.8

8.33

8.64

kpa

0.18

Other and unspecified types of non-Hodgkin lymphoma, hilmo

337

1.87

5.05

3.8

5.3

8.32

8.37

kpa

0.07

332

Corneal ulcer

223

1626

1.38

5.05

4.5

4.1

8.78

8.74

kpa

0.12

216

1594

Calcific tendinitis of shoulder

366

1.82

5.01

3.9

4.4

8.75

8.74

kpa

0.00

357

Malignant neoplasm of other endocrine glands and related structures, including Hilmo

6.34

5.00

3.6

1.7

8.78

8.10

kpa

0.61

Salpingitis and oophoritis

176

1235

1.43

4.98

5.1

3.1

8.81

8.65

kpa

0.57

170

1216

Other specified congenital malformation syndromes affecting multiple systems

2.79

4.98

6.3

5.6

8.98

9.03

kpa

0.04

Diseases of inner ear

693

5555

1.20

4.98

4.0

8.63

8.56

kpa

0.56

674

5424

Injuries to the wrist and hand

1323

7695

1.14

4.97

3.7

4.0

8.78

8.71

kpa

0.89

1285

7519

Magnesium deficiency

8.25

4.95

4.2

1.8

8.12

9.03

kpa

—

Any event in hilmo or specialist outpatient

+∞

4.94

3.7

0.0

10.28

—

kpa

—

Malignant neoplasm of meninges, including Hilmo

6.92

4.88

2.5

2.1

8.69

8.05

kpa

0.47

Autoimmune hyperthyroidism

355

1.82

4.86

3.5

3.4

8.82

8.78

kpa

0.06

350

Tobacco use

385

1.79

4.85

6.1

4.4

8.21

8.78

kpa

1.77

379

Other epidermal thickening

357

1.82

4.81

6.1

4.5

8.57

8.58

kpa

0.01

352

Other intervertebral disc disorders

1000

5137

1.16

4.80

3.8

3.9

8.71

8.65

kpa

0.52

976

5009

Status post-ami

300

1739

1.32

4.79

4.8

3.8

8.08

8.46

kpa

3.40

293

1689

Cachexia

4.91

4.77

7.6

3.6

7.81

8.30

kpa

0.50

Social disorders starting during childhood or adolecense, excluding more controls

4.83

4.74

9.9

8.4

9.84

8.38

kpa

1.42

Acute appendicitis, no complications

644

5358

1.20

4.72

3.5

3.9

8.90

8.79

kpa

0.84

632

5238

Other disorders of skin and subcutaneous tissue, not elsewhere classified

176

1249

1.42

4.72

6.2

4.1

8.50

8.54

kpa

0.12

171

1225

Menorrhagia

348

1506

1.29

4.71

3.0

3.5

8.79

8.71

kpa

0.38

339

1466

Malignant neoplasm of adrenal gland, including Hilmo

4.47

4.70

3.4

3.9

8.39

8.65

kpa

0.27

Other salmonella infections

246

1.98

4.67

3.8

3.9

8.56

8.63

kpa

0.10

241

Etanercept

449

1.71

4.67

2.7

3.9

8.47

8.86

kpa

1.30

443

Preparatory care for dialysis

339

1.83

4.66

15.7

5.0

9.31

8.52

kpa

3.15

334

Synovial hypertrophy, not elsewhere classified

3.59

4.66

2.1

2.8

9.45

9.13

kpa

0.27

Other enthesopathies

330

2576

1.29

4.66

3.6

3.9

8.67

kpa

0.00

320

2511

Disorders of synovium and tendon

643

4563

1.20

4.65

4.0

3.9

8.85

8.68

kpa

1.58

627

4440

Carcinoma in situ of other and unspecified sites

369

1.80

4.64

3.7

5.5

8.38

8.34

kpa

0.09

364

Actinic keratosis

532

3984

1.22

4.64

4.6

4.2

8.56

8.36

kpa

2.18

524

3881

Endometriosis

346

1565

1.29

4.63

2.8

3.5

8.90

8.76

kpa

0.64

340

1524

Otitis externa

276

2111

1.31

4.58

4.5

4.1

8.90

8.74

kpa

0.83

268

2073

Papulosquamous disorders

474

3868

1.23

4.57

4.0

8.43

8.67

kpa

2.35

468

3776

Perineal laceration during delivery

894

0.58

4.52

2.1

2.8

8.86

9.26

kpa

1.30

878

Injury of eye and orbit

163

1151

1.43

4.51

3.6

4.2

8.95

8.80

kpa

0.60

158

1131

Temporal arteritis

293

1.88

4.47

6.0

4.8

8.56

8.38

kpa

0.31

288

Other specific joint derangements/joint disorders

854

4560

1.17

4.47

4.1

3.8

8.84

8.81

kpa

0.16

832

4448

Carcinoma in situ, bladder

337

1.82

4.46

3.6

5.4

8.33

8.35

kpa

0.04

332

Herpesviral keratitis and keratoconjunctivitis

315

1.84

4.44

5.7

4.5

8.71

8.52

kpa

0.42

309

Pregnancy hypertension

373

2654

1.26

4.43

3.0

3.2

9.06

8.89

kpa

1.01

365

2602

Fibrosis of liver

3.33

4.41

8.3

2.8

8.49

8.73

kpa

0.15

Skin changes due to chronic exposure to nonionizing radiation

541

4062

1.21

4.40

4.6

4.2

8.56

8.37

kpa

2.03

533

3958

Leiomyosarcoma

3.47

4.39

4.3

3.1

9.36

8.33

kpa

1.04

Other mental disorders due to brain damage and dysfunction and to physical disease

159

1125

1.43

4.38

4.0

4.6

8.47

8.44

kpa

0.08

153

1103

Social disorders starting during childhood or adolescence

4.39

4.37

9.9

7.8

9.84

9.03

kpa

0.68

Any dementia, excluding more controls

492

2767

1.23

4.37

4.2

4.1

8.05

8.40

kpa

5.19

471

2709

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

4.80

4.36

4.8

2.7

8.77

8.83

kpa

0.03

Giant cell arteritis with polymyalgia rheumatica

297

1.85

4.30

6.0

4.8

8.56

8.38

kpa

0.30

292

Reactive arthropathies

101

655

1.56

4.30

6.1

4.1

8.37

8.72

kpa

1.34

639

Neuralgia and neuritis, unspecified

341

1.78

4.26

3.0

4.4

9.01

8.67

kpa

0.95

334

Examination and encounter for administrative purposes

980

0.58

4.24

4.0

4.2

8.94

8.49

kpa

1.20

961

Alzheimer’s disease, strict definition

237

2506

0.76

4.21

3.7

4.4

7.89

8.27

kpa

4.00

227

2431

Subjective visual disturbances

299

2345

1.28

4.14

3.7

3.9

8.87

8.66

kpa

1.55

293

2297

Other disorders of central nervous system

2.78

4.13

2.7

3.7

8.66

8.79

kpa

0.12

Restless leg syndrome

171

1239

1.39

4.12

3.4

4.2

8.84

8.58

kpa

1.16

165

1217

Giant cell arteritis

338

1.77

4.12

5.8

4.7

8.46

8.37

kpa

0.14

333

Carpal tunnel syndrome

745

5537

1.17

4.08

3.8

3.9

8.66

8.61

kpa

0.25

731

5403

5.28

4.08

2.5

4.1

8.70

9.57

kpa

0.65

Malignant neoplasm of adrenal gland

5.27

4.08

3.4

4.2

8.36

8.28

kpa

0.07

Lupus nephritis

6.76

4.05

8.4

1.7

8.98

9.21

kpa

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Oxygen [Partial pressure] in Blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS